Bacterial infectious disease
MONDO:0005113An acute infectious disorder that is caused by gram positive or gram negative bacteria; representative examples include pneumococcal, streptococcal, salmonella, and meningeal infections.
Also known as: Bacteria caused disease or disorder, Bacteria disease or disorder, Bacteria infectious disease, bacterial disease, bacterial disorder, bacterial infection, bacterial infectious disease, infection, bacterial
1771 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsSub-types
Broader categories
-
Could a higher dose of rifampicin cut TB treatment time for kids?
⭐️ CURE ⭐️ Not yet recruitingThis study tests whether a higher dose of the drug rifampicin can safely shorten tuberculosis treatment for children aged 3 months to 10 years. About 230 children with drug-susceptible TB will receive either the standard or a higher rifampicin dose, with treatment duration adjust…
Phase: PHASE2 • Sponsor: University of Wisconsin, Madison • Aim: ⭐️ CURE ⭐️
Last updated Jun 27, 2026 14:00 UTC
-
Personalized TB treatment could shorten recovery time
⭐️ CURE ⭐️ Not yet recruitingThis study tests whether tuberculosis (TB) treatment can be tailored to each person's risk of a poor outcome. About 900 adults with drug-sensitive TB will be grouped as lower-risk or higher-risk. Lower-risk participants may get a shorter treatment course, while higher-risk partic…
Phase: PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: ⭐️ CURE ⭐️
Last updated Jun 27, 2026 14:00 UTC
-
New vaccine aims to tackle multiple salmonella strains at once
⭐️ VACCINE ⭐️ Not yet recruitingThis study tests a new quadrivalent Pan-Salmonella vaccine designed to protect against several types of Salmonella bacteria that cause typhoid and paratyphoid fevers. Healthy adults aged 18 to 45 in Africa receive either a low or full dose of the vaccine, with or without an adjuv…
Phase: PHASE1 • Sponsor: GlaxoSmithKline • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 14:03 UTC
-
New vaccine aims to stop deadly diarrhea in kids
⭐️ VACCINE ⭐️ Not yet recruitingThis study tests a new vaccine (IP-QSV) designed to protect against four types of Shigella bacteria, which cause severe diarrhea. The trial will include 370 healthy adults, children, and infants in Mali. Researchers will check if the vaccine is safe and triggers a strong immune r…
Phase: PHASE1, PHASE2 • Sponsor: International Vaccine Institute • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 14:02 UTC
-
New TB vaccine candidate enters human testing
⭐️ VACCINE ⭐️ Not yet recruitingThis study tests an experimental tuberculosis vaccine called Lipovaxin in healthy adults aged 18 to 40 in Indonesia. The vaccine is given as two shots, 28 days apart, and compared to a placebo. The main goals are to check if the vaccine is safe and whether it triggers an immune r…
Phase: PHASE1 • Sponsor: PT Bio Farma • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 14:00 UTC
-
No-Needle tetanus shot? new patch trial begins
⭐️ VACCINE ⭐️ Not yet recruitingThis first-in-human study tests a new microneedle patch (Miracus) that dissolves in the skin to deliver a tetanus vaccine without a needle. Thirty healthy adults will receive either an empty patch or one loaded with vaccine. Researchers will check safety, tolerability, and whethe…
Phase: PHASE4 • Sponsor: Microneedle Solutions Ltd • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 13:02 UTC
-
New vaccine for moms could shield babies from whooping cough
⭐️ VACCINE ⭐️ Not yet recruitingThis study tests a new vaccine called TdaP2gen in 320 pregnant women in Thailand to see if it safely protects their babies from tetanus, diphtheria, and whooping cough. The vaccine is given during pregnancy, and researchers measure antibody levels in mothers and infants up to 18 …
Phase: PHASE4 • Sponsor: Chiang Mai University • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 13:01 UTC
-
Korea launches safety watch on meningitis vaccine MenQuadfi
⭐️ VACCINE ⭐️ Not yet recruitingThis study will monitor the safety of the MenQuadfi vaccine in 706 people aged 6 weeks to 55 years in South Korea. Researchers will track side effects like injection-site reactions and serious adverse events as the vaccine is used in real-world clinics. The goal is to confirm the…
Sponsor: Sanofi • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 13:00 UTC
-
New tetanus vaccine enters first human safety tests
⭐️ VACCINE ⭐️ Not yet recruitingThis early-stage trial is testing a new tetanus vaccine in 80 adults aged 18 and older. The study is randomized and double-blind, meaning neither participants nor doctors know who gets the new vaccine versus an existing one. The main goal is to check for side effects within the f…
Phase: PHASE1 • Sponsor: Aimei Vacin BioPharm (Zhejiang) Co., Ltd. • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:36 UTC
-
New 24-Strain pneumonia vaccine enters human trials
⭐️ VACCINE ⭐️ Not yet recruitingThis study tests a new vaccine (PCV24) designed to protect against 24 types of pneumococcal bacteria, which can cause pneumonia, meningitis, and ear infections. The trial includes 854 healthy people aged 2 months and older, split into two phases to check safety and immune respons…
Phase: PHASE1, PHASE2 • Sponsor: CanSino Biologics Inc. • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:36 UTC
-
New baby vaccine could fight pneumonia
⭐️ VACCINE ⭐️ Not yet recruitingThis study tests a new vaccine to protect babies against pneumococcal infections, which can cause pneumonia and meningitis. About 500 healthy infants will receive either the new vaccine or an existing one. Researchers will check if the new vaccine triggers a strong immune respons…
Phase: PHASE3 • Sponsor: Sinovac Life Sciences Co., Ltd. • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:35 UTC
-
Can a vaccine boost TB treatment? new trial aims to find out
⭐️ VACCINE ⭐️ Not yet recruitingThis study tests an experimental vaccine called ID93 + GLA-SE in 1500 people with drug-susceptible pulmonary TB. Participants receive the vaccine or a placebo alongside their regular TB treatment. Researchers want to see if the vaccine can improve immune responses and reduce poor…
Phase: PHASE2 • Sponsor: Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:05 UTC
-
New meningitis vaccine trial aims to shield babies from deadly infection
⭐️ VACCINE ⭐️ Not yet recruitingThis Phase 3 trial tests a new vaccine designed to protect infants aged 3 to 5 months against four strains of meningococcal bacteria that cause meningitis and sepsis. About 880 healthy babies will receive either the experimental vaccine or a licensed comparator vaccine. Researche…
Phase: PHASE3 • Sponsor: Sinovac Biotech Co., Ltd • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:03 UTC
-
New meningitis vaccine for kids shows promise in large trial
⭐️ VACCINE ⭐️ Not yet recruitingThis Phase 3 trial tests a new meningococcal conjugate vaccine in 660 healthy children aged 2-6 years. The vaccine targets four strains (A, C, Y, W135) that cause meningitis. Participants receive one shot and provide blood samples to compare immune response with a licensed vaccin…
Phase: PHASE3 • Sponsor: Sinovac Biotech Co., Ltd • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:03 UTC
-
New meningitis vaccine for toddlers shows promise in major trial
⭐️ VACCINE ⭐️ Not yet recruitingThis study tests a new vaccine to protect young children (12-23 months old) against four types of meningococcal bacteria that can cause meningitis. About 1,040 toddlers will receive either the new vaccine or an existing one to see if the new vaccine is as safe and effective. The …
Phase: PHASE3 • Sponsor: Sinovac Biotech Co., Ltd • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:03 UTC
-
New meningitis vaccine trial aims to protect babies
⭐️ VACCINE ⭐️ Not yet recruitingThis Phase 3 trial tests a new vaccine against four types of meningococcal bacteria (A, C, Y, W135) that cause meningitis. About 1,040 healthy infants aged 6 to 11 months will receive either the experimental vaccine or a licensed comparator. Researchers will measure immune respon…
Phase: PHASE3 • Sponsor: Sinovac Biotech Co., Ltd • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:02 UTC
-
New cholera pill tested in sweden – first human study begins
⭐️ VACCINE ⭐️ Not yet recruitingThis early-stage study tests a new oral cholera vaccine called DuoChol in 60 healthy adults aged 18 to 45 in Sweden. Participants will receive two doses of either DuoChol or an existing vaccine (Dukoral) to compare safety and immune response. The goal is to gather initial data to…
Phase: PHASE1 • Sponsor: International Vaccine Institute • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:02 UTC
-
New vaccine trial aims to shield teens and adults from whooping cough
⭐️ VACCINE ⭐️ Not yet recruitingThis early-stage trial is testing a new combination vaccine that protects against whooping cough, diphtheria, and tetanus (Tdap) in people aged 10 and older. Researchers want to see if different doses are safe and trigger an immune response. The study involves 96 volunteers and c…
Phase: PHASE1 • Sponsor: Changchun BCHT Biotechnology Co. • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:00 UTC
-
New Low-Dose tdap vaccine trial aims to boost protection with fewer side effects
⭐️ VACCINE ⭐️ Not yet recruitingThis study tests a new version of the Tdap vaccine (which protects against tetanus, diphtheria, and whooping cough) that has reduced antigens. The goal is to see if it is safe and triggers a strong immune response in people aged 6 and up. Around 660 volunteers will receive either…
Phase: PHASE1, PHASE2 • Sponsor: Institute of Medical Biology, Chinese Academy of Medical Sciences • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 09:06 UTC
-
New pneumonia vaccine booster for toddlers enters safety trial
⭐️ VACCINE ⭐️ Not yet recruitingThis early-stage study tests a new pneumococcal vaccine booster in 45 toddlers aged 12-15 months who already received their routine pneumonia shots. The goal is to check for side effects like tenderness, fever, and sleepiness. The study compares the new vaccine to an existing one…
Phase: PHASE1 • Sponsor: GlaxoSmithKline • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 09:05 UTC
-
New meningitis vaccine enters first human tests
⭐️ VACCINE ⭐️ Not yet recruitingThis early-stage trial is testing a new vaccine designed to protect against several types of meningococcal bacteria, which can cause meningitis and bloodstream infections. Researchers will enroll 150 healthy people aged 2 to 59 to check the vaccine's safety and how well it trigge…
Phase: PHASE1 • Sponsor: Sinovac Life Sciences Co., Ltd. • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 09:00 UTC
-
Shigella vaccine immunity checked years later in african kids
⭐️ VACCINE ⭐️ Not yet recruitingThis study follows up on African children who received an experimental Shigella vaccine in earlier studies. Researchers will take blood samples 1, 2, and 3 years after the last vaccine dose to see how long the immune protection lasts. No new vaccines are given in this study. The …
Phase: PHASE2 • Sponsor: GlaxoSmithKline • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 08:08 UTC
-
Can a pneumonia vaccine protect the most vulnerable children?
⭐️ VACCINE ⭐️ Not yet recruitingThis study tests whether a pneumococcal vaccine (Pneumosil) can produce a strong immune response in children aged 6-59 months who are hospitalised with severe acute malnutrition. Half the children will receive the pneumococcal vaccine, and the other half will receive a typhoid va…
Phase: PHASE4 • Sponsor: Nick Fancourt • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 08:05 UTC
-
Blood filters aim to reverse organ failure in septic shock
Disease control Not yet recruitingThis study tests whether special blood purification devices can help people with septic shock, a life-threatening condition where infection causes organ failure. The trial includes adults aged 18 to 80 with severe septic shock. Depending on their level of endotoxins, patients rec…
Phase: NA • Sponsor: Moscow Multidisciplinary Clinical Center "Kommunarka" • Aim: Disease control
Last updated Jul 03, 2026 23:00 UTC
-
Faster, better baby tooth root canals? trial pits two rotary file systems Head-to-Head
Disease control Not yet recruitingThis trial compares two types of rotary files designed for children's primary molars: Fanta AF Baby and EndoArt Pedo Blue. The goal is to see which system prepares root canals faster and with better filling quality during a pulpectomy (removing infected pulp). Thirty children age…
Phase: NA • Sponsor: Cairo University • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Nasal spray ingredient may offer safer dental pulp treatment for kids
Disease control Not yet recruitingThis study tests whether oxymetazoline, a common nasal decongestant, can replace sodium hypochlorite as a bleeding control agent during pulp treatment in children's baby teeth. About 50 Egyptian children aged 4-8 with decayed molars will receive either treatment. The goal is to s…
Phase: NA • Sponsor: Cairo University • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New TB cocktail aims to shorten treatment
Disease control Not yet recruitingThis study tests a new combination of three drugs—sorfequiline, pretomanid, and linezolid—in 100 adults with newly diagnosed, drug-sensitive tuberculosis. Participants take the pills daily for 17 weeks. The goal is to see if the combo is safe and can clear the infection faster th…
Phase: PHASE2 • Sponsor: Global Alliance for TB Drug Development • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New 6-Month drug cocktail aims to tame resistant TB
Disease control Not yet recruitingThis phase 3 trial tests whether a 6-month combination of five drugs (bedaquiline, delamanid, delpazolid, levofloxacin, and pyrazinamide) works as well as standard treatment for rifampicin-resistant tuberculosis in adults and adolescents aged 15 and older in South Africa. The stu…
Phase: PHASE3 • Sponsor: Seoul National University Hospital • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Engineered yeast pill takes on superbug c. diff in first human trial
Disease control Not yet recruitingThis early-stage trial tests an oral capsule containing a genetically modified probiotic yeast designed to neutralize toxins produced by C. diff bacteria. The study first evaluates safety in healthy adults, then in people at risk for recurrent C. diff infection. Participants take…
Phase: PHASE1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
Shorter TB regimens could simplify treatment
Disease control Not yet recruitingThis study looks at whether shorter, rifapentine-based treatments for tuberculosis and latent TB are safe and effective in real-world settings in Kazakhstan. It will follow 350 adults, including those with HIV, comparing a 4-month regimen to the standard 6-month one for active TB…
Sponsor: Public Union "Kazakhstan Association of Phthisiopulmonologists" • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New vaginal capsule aims to tackle stubborn bacterial vaginosis
Disease control Not yet recruitingThis study tests a new drug called GenSci142, given as a vaginal capsule, for treating bacterial vaginosis (BV). About 30 women with BV will receive either GenSci142 or a standard antibiotic cream to compare safety and how well each works. The goal is to see if the new capsule is…
Phase: PHASE1 • Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New hope for brain infection: experimental combo tackles tuberculous meningitis
Disease control Not yet recruitingThis study tests a new combination of medicines (BPaLMZ) against the standard treatment for tuberculous meningitis, a serious brain infection. About 240 adults, including those living with HIV, will take part. The goal is to see if the new combo helps more people survive and reco…
Phase: PHASE2 • Sponsor: University of Minnesota • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Could a gentler antibiotic beat gonorrhea without fueling superbugs?
Disease control Not yet recruitingThis phase 3 trial compares a single intravenous dose of temocillin to the standard ceftriaxone shot for treating gonorrhea. The goal is to see if temocillin works just as well while having less impact on the gut's healthy bacteria, which can help prevent the rise of drug-resista…
Phase: PHASE3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Blood filter targets DNA to tame septic shock inflammation
Disease control Not yet recruitingThis trial tests a device called Nucleocore that removes cell-free DNA (cfDNA) from the blood of people with septic shock. High cfDNA levels are linked to severe inflammation and worse outcomes. The study enrolls adults aged 18-65 with septic shock and elevated cfDNA, and measure…
Phase: NA • Sponsor: Sergey Savko • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Can two antibiotics beat one for Drug-Resistant typhoid?
Disease control Not yet recruitingThis study compares giving one antibiotic (meropenem) versus two antibiotics (meropenem plus azithromycin) to children aged 2–16 with extensively drug-resistant (XDR) typhoid fever. The goal is to see which approach shortens fever faster. 94 children will be randomly assigned to …
Phase: NA • Sponsor: Iqra Asghar Ali • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Triple-Action nasal spray could ease chronic sinusitis
Disease control Not yet recruitingThis early-stage trial tests a nasal spray for adults with chronic sinusitis (without polyps). The spray contains stem cell exosomes to heal the nose lining, an antibiotic to kill bacteria, and an enzyme to break up thick mucus. 108 participants will use the spray twice daily for…
Phase: EARLY_PHASE1 • Sponsor: The First Affiliated Hospital of Xinxiang Medical College • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
New HIV combo pill tested alongside TB treatment in small trial
Disease control Not yet recruitingThis study will compare two different HIV medication combinations in 60 people who also have active tuberculosis. Participants will receive either a newer drug (Ainuovirine) or a standard one (Efavirenz), along with their TB meds. The goal is to see which regimen better suppresse…
Phase: PHASE4 • Sponsor: Shanghai Public Health Clinical Center • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Ancient toothbrush plant tested as a modern pulp saver
Disease control Not yet recruitingThis study tests whether a paste made from Salvadora persica (a plant used in traditional toothbrushes) mixed with zinc oxide can work as well as the standard material (MTA) for treating severe tooth inflammation. The trial involves 78 adults aged 18-40 with infected permanent mo…
Phase: NA • Sponsor: Postgraduate Medical Institute, Lahore • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
Could a new drug beat the current standard for septic shock?
Disease control Not yet recruitingThis study tests whether a drug called Angiotensin II works better than the usual treatment (norepinephrine) for people with septic shock, a life-threatening condition where blood pressure drops dangerously. About 78 adults with septic shock will receive either Angiotensin II or …
Phase: PHASE4 • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Simpler h. pylori treatment could reduce antibiotic use
Disease control Not yet recruitingThis study tests whether a simpler two-drug treatment (vonoprazan plus one antibiotic) works as well as a three-drug treatment (vonoprazan plus two antibiotics) for H. pylori infection. About 150 adults with confirmed H. pylori will take either regimen for 14 days. The main goal …
Phase: PHASE4 • Sponsor: Damascus Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
New combo treatment aims to slash sepsis deaths in HIV patients
Disease control Not yet recruitingThis phase 3 trial tests whether adding a steroid (hydrocortisone) and a stronger mix of antibiotics to standard care can improve survival in HIV patients with sepsis in sub-Saharan Africa. The study will enroll 344 adults and measure how many are alive after 28 days. It aims to …
Phase: PHASE3 • Sponsor: University of Virginia • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Ancient herbs meet modern viruses in fight against superbug pneumonia
Disease control Not yet recruitingThis early-phase trial will test a combination of a Chinese herbal formula (Yiqi Huoxue Jiedu) and bacteriophages (viruses that target bacteria) in 250 people with severe pneumonia caused by drug-resistant bacteria. The goal is to see if this combo can clear the infection faster …
Phase: EARLY_PHASE1 • Sponsor: Chinese PLA General Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Can a saline flush during labor shield newborn brains?
Disease control Not yet recruitingThis study tests whether infusing fluid into the uterus during labor (amnioinfusion) can reduce brain injury in newborns whose mothers have a uterine infection called chorioamnionitis. The infection can cause inflammation and fever that may stress the baby's brain before birth. R…
Phase: NA • Sponsor: Medical College of Wisconsin • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Shorter TB course could be Game-Changer for HIV patients
Disease control Not yet recruitingThis study tests whether a shorter, 5-month combination of TB drugs works as well as the standard 6-month treatment for people with both HIV and drug-susceptible tuberculosis. It involves 148 participants with very weak immune systems (CD4 count under 100). The goal is to see if …
Phase: NA • Sponsor: Shanghai Public Health Clinical Center • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
Rosemary vs. root canal: could a kitchen herb save your tooth?
Disease control Not yet recruitingThis study compares rosemary extract to a standard material (MTA) for treating severe tooth pulp inflammation. Researchers will treat 100 adults with a damaged tooth, placing either rosemary extract or MTA directly on the pulp. They will then measure pain and healing over time to…
Phase: NA • Sponsor: University of Health Sciences Lahore • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New acid reducer shows promise in fighting stomach bug
Disease control Not yet recruitingThis Phase 3 trial tests whether a new acid-reducing drug, anaprazole, works better than the standard drug esomeprazole when used with bismuth and two antibiotics to treat H. pylori infection. About 556 adults in China will take either anaprazole or esomeprazole pills twice daily…
Phase: PHASE3 • Sponsor: Xuanzhu Biopharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Virus cocktail targets superbug pneumonia in first human test
Disease control Not yet recruitingThis early-stage trial tests MP101, a mix of two viruses that attack bacteria (phages), in 18 adults with Pseudomonas aeruginosa pneumonia. Participants receive a single dose of MP101 or a placebo alongside standard antibiotics. The main goal is to check safety and how the body h…
Phase: PHASE1 • Sponsor: MicrobiotiX Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New booster vaccine trial aims to shield japanese teens from three serious diseases
Disease control Not yet recruitingThis study tests a single booster dose of a combined vaccine against diphtheria, tetanus, and whooping cough (dTpa) in 85 healthy Japanese adolescents aged 11 to 13. Researchers will check if the shot triggers a strong immune response and monitor for side effects one month after …
Phase: PHASE3 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Sound waves and bubbles take on stubborn joint infections
Disease control Not yet recruitingThis study tests a new way to treat infected knee replacements. About 100 adults having surgery for an infected knee will be randomly assigned to receive either standard care or standard care plus an extra treatment. The extra treatment involves injecting antibiotics along with s…
Phase: PHASE2 • Sponsor: Thomas Jefferson University • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Can saline alone treat lung infections? new pilot study aims to find out
Disease control Not yet recruitingThis pilot study will test whether flushing the chest tube with saline alone can treat complicated pleural infections (fluid buildup around the lungs). If saline doesn't work, patients will receive stronger clot-busting drugs (fibrinolytics) or surgery. The study will track how l…
Phase: PHASE4 • Sponsor: Dartmouth-Hitchcock Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Could a 'Vaginal microbiome Transplant' stop recurring BV?
Disease control Not yet recruitingThis phase 2 trial tests whether transferring vaginal fluid from healthy donors can help women aged 18-25 with recurrent bacterial vaginosis (BV). Participants first receive standard antibiotics, then the transplant. The goal is to see if this restores a healthy vaginal microbiom…
Phase: PHASE2 • Sponsor: Douglas Kwon • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New drug cocktail aims to beat tough infection in HIV patients
Disease control Not yet recruitingThis trial tests whether adding a fluoroquinolone antibiotic to the standard three-drug treatment helps HIV patients with a serious bacterial infection called disseminated MAC. About 124 adults will be randomly assigned to get either the standard therapy or the four-drug combo fo…
Phase: NA • Sponsor: Shanghai Public Health Clinical Center • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Can a new drug help sepsis patients with weak immune systems?
Disease control Not yet recruitingThis Phase 2 trial tests whether adding the drug nogapendekin alfa inbakicept (NAI) to standard sepsis care can improve survival in critically ill adults with sepsis and persistently low lymphocyte counts (a sign of immune suppression). About 50 participants will be randomly assi…
Phase: PHASE2 • Sponsor: ImmunityBio, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Could a simple paste replace drilling for Kids' tooth infections?
Disease control Not yet recruitingThis study compares a new, simpler treatment called CTZ paste against the standard root canal procedure for infected baby teeth in emergency settings. The CTZ paste is placed directly into the tooth without drilling or cleaning the root canals, aiming to kill bacteria and save th…
Phase: EARLY_PHASE1 • Sponsor: University of Sao Paulo • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Can a cancer drug wake up immune cells to beat HIV-Related infections?
Disease control Not yet recruitingThis study tests a drug called Sintilimab, which is normally used for cancer, to see if it can help people with HIV who have infections that won't go away with standard treatment. The drug works by 'waking up' exhausted immune cells. Fifty adults with HIV and a hard-to-treat infe…
Phase: PHASE1, PHASE2 • Sponsor: Shanghai Public Health Clinical Center • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
New study tests cheaper h. pylori treatment to beat antibiotic resistance
Disease control Not yet recruitingThis study compares two 14-day treatments for H. pylori, a stomach bacteria that can cause ulcers and cancer. About 90 adults will receive either a levofloxacin-based sequential therapy or a bismuth-based quadruple therapy. The goal is to see which treatment works better and has …
Phase: NA • Sponsor: University of Health Sciences Lahore • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Can calming the nervous system save lives in septic shock?
Disease control Not yet recruitingThis study tests whether a sedative called dexmedetomidine can improve survival in people with refractory septic shock, a life-threatening condition where blood pressure stays dangerously low despite standard treatments. The drug aims to calm an overactive stress response that ma…
Phase: PHASE3 • Sponsor: Hospices Civils de Lyon • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Oxygen chamber therapy put to the test for dozens of diseases
Disease control Not yet recruitingThis study will test hyperbaric oxygen therapy (HBOT) — breathing pure oxygen in a pressurized chamber — for over 30 conditions, including long COVID, Crohn's disease, frostbite, and multiple sclerosis. Researchers will track 100 patients to see if HBOT improves their quality of …
Phase: PHASE4 • Sponsor: Jay C. Buckey Jr. • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Could a Two-Antibiotic cocktail prevent infections after water breaks?
Disease control Not yet recruitingThis study looks at whether giving two antibiotics (ampicillin and gentamicin) instead of one (ampicillin alone) can better prevent infections in pregnant women whose water breaks before labor starts. About 320 women at term will be randomly assigned to one of the two treatments.…
Phase: PHASE4 • Sponsor: Sarawak General Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New antibiotic strategy could shorten hospital stays for heart infections
Disease control Not yet recruitingThis pilot study tests a long-acting antibiotic called oritavancin for treating gram-positive heart infections, such as infective endocarditis. The goal is to see if weekly IV doses can replace the usual weeks-long hospital stays and daily antibiotics. The study will enroll 20 ad…
Phase: PHASE2 • Sponsor: Kirby Institute • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Which antibiotic combo is safer for your kidneys? new trial aims to find out
Disease control Not yet recruitingThis study compares two common antibiotic combinations—vancomycin with piperacillin/tazobactam versus vancomycin with meropenem—to see which is less harmful to the kidneys. About 852 hospitalized adults with serious infections will be randomly assigned to one of the two combos. T…
Phase: PHASE4 • Sponsor: Bassett Healthcare • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
One-Stop clinic aims to cut infections in veterans with opioid disorder
Disease control Not yet recruitingThis study tests a new care model for veterans with opioid use disorder that combines infectious disease screening and treatment with their usual medication-assisted therapy in a single appointment. The goal is to make it easier for veterans to get tested and treated for infectio…
Phase: NA • Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Compression stockings may let patients skip Long-Term antibiotics for recurring skin infections
Disease control Not yet recruitingThis study tests whether wearing compression stockings alone can prevent repeat episodes of erysipelas (a bacterial skin infection) as well as the usual approach of antibiotics plus stockings. About 200 adults who have had at least two infections in the same leg will be randomly …
Phase: PHASE4 • Sponsor: University Hospital, Tours • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Nurse education program aims to boost TB treatment success
Disease control Not yet recruitingThis study tests whether adding nurse-led educational sessions helps people with tuberculosis stick to their treatment plan. About 40 adults recently diagnosed with TB will receive extra guidance from nurses. The goal is to see if this support improves treatment completion and re…
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Stop the pills when symptoms vanish? landmark trial for Kids' infections
Disease control Not yet recruitingThis study tests whether children with bacterial infections like urinary tract infections, cellulitis, or pneumonia can safely stop oral antibiotics once their symptoms go away, instead of finishing the entire course. About 200 children aged 1 to 17 who have already received IV a…
Phase: PHASE4 • Sponsor: Murdoch Childrens Research Institute • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Can a probiotic stop bacterial vaginosis recurrence?
Disease control Not yet recruitingThis study tests whether a probiotic called Lactobacillus gasseri KABP®064 can prevent bacterial vaginosis (BV) from returning after standard antibiotic treatment. BV is a common vaginal infection that often comes back within a year. The trial will involve 160 women with a histor…
Phase: PHASE2, PHASE3 • Sponsor: Kaneka Americas Holding Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Stool test could replace endoscopy for stubborn stomach bug
Disease control Not yet recruitingThis study tests a new way to treat Helicobacter pylori (H. pylori) infections that didn't get better with the first round of antibiotics. Instead of using a scope to take a stomach sample, doctors will use a stool test to find which antibiotics will work best. About 531 adults w…
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
New dental cement could save Kids' teeth without root canals
Disease control Not yet recruitingThis study tests three special dental cements—Bio C Repair, Biodentine, and MTA—as treatments for irreversible pulpitis (nerve infection) in children's permanent molars. Sixty kids aged 6-10 will receive one of the materials after removing the infected pulp. The goal is to see wh…
Phase: NA • Sponsor: Cairo University • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New pill aims to break the cycle of repeat c. diff infections
Disease control Not yet recruitingThis phase 2 trial tests an oral drug called ibezapolstat in 20 people who have had three or more C. diff infections in the past year. The goal is to see if the drug can cure the current infection and reduce the chance of it coming back. Participants will take the drug twice a da…
Phase: PHASE2 • Sponsor: Acurx Pharmaceuticals Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Could viruses be the new antibiotics for joint infections?
Disease control Not yet recruitingThis study tests whether a treatment using special viruses (called phages) can safely and effectively treat infections in hip or knee replacements caused by Staphylococcus aureus bacteria. About 100 adults will receive either the phage therapy or a placebo during a standard surge…
Phase: PHASE2 • Sponsor: Phagenix • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Veterans' stomach bug battle: tailored treatment may beat standard care
Disease control Not yet recruitingThis study compares a personalized treatment plan for H. pylori infection against the usual standard care in 360 veterans. The personalized approach uses genetic testing and antibiotic sensitivity to choose the best drugs. The goal is to see which method cures more infections wit…
Phase: PHASE3 • Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Could a common diabetes pill protect the brain after a stroke?
Disease control Not yet recruitingThis study tests whether canagliflozin, a diabetes drug, can reduce dangerous brain swelling and bleeding in people who have had a severe stroke and are receiving clot-removal therapy. About 150 adults will be randomly assigned to take the drug for 14 days or receive standard car…
Phase: PHASE4 • Sponsor: Taichung Veterans General Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Could a sleep hormone help fight superbugs?
Disease control Not yet recruitingThis study tests whether adding melatonin to the strong antibiotic colistin helps patients with multidrug-resistant bacterial infections. These infections are hard to treat and often deadly. The trial will give 70 adults either melatonin or a placebo alongside their regular treat…
Phase: PHASE3 • Sponsor: Ain Shams University • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Brain injection method could revolutionize meningitis treatment
Disease control Not yet recruitingThis study tests a new method of giving antibiotics for moderate-to-severe bacterial meningitis. Instead of only giving antibiotics through a vein, doctors will also inject them into the skull bone to help more medicine reach the brain. The goal is to improve recovery in 86 adult…
Phase: NA • Sponsor: yilong Wang • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Could a diabetes pill save lives in septic shock?
Disease control Not yet recruitingThis study tests whether dapagliflozin, a drug used for diabetes, can help people with septic shock—a severe infection that causes organ failure. The drug aims to protect blood vessels and reduce inflammation. About 568 ICU patients will receive either dapagliflozin or a placebo,…
Phase: PHASE3 • Sponsor: University Hospital, Strasbourg, France • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Fish oil and eyelid wipes: a new hope for Kids' stubborn styes?
Disease control Not yet recruitingThis study tests whether omega-3 supplements or a special anti-demodex eyelid cleanser can help treat and prevent chalazia (styes) in children aged 4 to 17. All 168 participants will use warm compresses, and they will be split into three groups: one adds omega-3 fish oil and stan…
Phase: PHASE2 • Sponsor: Jaeb Center for Health Research • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Good bacteria vs. bad: new trial aims to stop BV from coming back
Disease control Not yet recruitingThis study tests whether a probiotic supplement containing Lactobacillus crispatus can reduce the number of times bacterial vaginosis (BV) comes back in women who have had it repeatedly. About 156 women aged 18-45 will take either the probiotic or a placebo daily for 12 weeks aft…
Phase: NA • Sponsor: Liaquat University of Medical & Health Sciences • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Can vitamin c save kidneys in liver failure patients?
Disease control Not yet recruitingThis study looks at whether giving vitamin C through a vein can help very sick patients with liver failure and severe infections recover from kidney injury. About 110 patients will get either standard care alone or standard care plus vitamin C. The goal is to see if vitamin C hel…
Phase: NA • Sponsor: Institute of Liver and Biliary Sciences, India • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Could a special suture cut infection risk after joint replacement?
Disease control Not yet recruitingThis study tests whether antibiotic-coated braided sutures work as well as standard monofilament sutures in patients with infected hip or knee replacements. Surgeons currently use weaker monofilament sutures in infected cases to reduce bacterial growth. If the coated braided sutu…
Phase: NA • Sponsor: University of Miami • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Virus cocktail takes on stubborn diabetic foot infections
Disease control Not yet recruitingThis study tests whether adding a special virus mixture (phage therapy) to standard wound care can shrink diabetic foot ulcers infected with staph bacteria more than standard care alone. About 60 adults with diabetes and a foot ulcer that has lasted over 2 weeks will take part. T…
Phase: PHASE1, PHASE2 • Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Disease control
Last updated Jun 27, 2026 11:04 UTC
-
New 6-Month TB drug cocktail could replace Year-Long ordeal
Disease control Not yet recruitingThis study tests a new 6-month treatment called BPaLM for people with multidrug-resistant tuberculosis (MDR-TB). The goal is to see if it works as well as the current 18+ month regimen. About 55 adults in France will receive the shorter treatment, and their outcomes will be compa…
Phase: PHASE3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
New bacterial vaginosis treatment aims to rebalance vaginal flora
Disease control Not yet recruitingThis study tests a new treatment called FB301 in 120 women aged 18-45 with bacterial vaginosis (BV). Before FB301, some women will receive an antibiotic or a vaginal wash to see if that helps restore healthy bacteria. The goal is to improve the balance of good bacteria in the vag…
Phase: PHASE2 • Sponsor: Freya Biosciences ApS • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
New drug combo takes on rare, Drug-Resistant lung bug
Disease control Not yet recruitingThis trial tests a new combination of antibiotics (called Arm D) against standard treatments for a rare lung infection caused by Mycobacterium abscessus. About 300 people with or without cystic fibrosis will take part. The goal is to see if the new combo clears the infection bett…
Phase: PHASE2 • Sponsor: The University of Queensland • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
New spinning tool may beat manual cleaning for kids' tooth infections
Disease control Not yet recruitingThis study tests whether a single rotary file system removes more bacteria from infected baby molars than traditional manual files. Thirty-four children aged 4 to 6 with irreversible pulpitis will have their root canals cleaned using one of the two methods. The main goal is to me…
Phase: NA • Sponsor: Cairo University • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Can a calming drug tame the deadly stress of sepsis?
Disease control Not yet recruitingThis study tests whether giving the sedative dexmedetomidine early to adults with septic shock can calm their overactive nervous system and improve survival. 168 participants will receive either the drug or a placebo for 48 hours, with close monitoring of heart function, inflamma…
Phase: PHASE4 • Sponsor: Sichuan Academy of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
AI-Designed TB treatment aims for 99.5% cure rate
Disease control Not yet recruitingThis Phase II trial tests whether an AI-optimized combination of pyrazinamide and hydroxychloroquine works better than the standard four-drug RIPE regimen for newly diagnosed drug-sensitive pulmonary tuberculosis. Two hundred adults will receive either the new AI-personalized tre…
Phase: PHASE2 • Sponsor: Ministry of Health, Saudi Arabia • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New hope for newborns: simpler syphilis treatment on trial
Disease control Not yet recruitingThis study tests whether a 10-day course of oral amoxicillin works as well as a single injected dose of penicillin to treat congenital syphilis in newborns up to 30 days old. About 374 infants across 12 U.S. sites will be randomly assigned to one of the two treatments. The goal i…
Phase: PHASE4 • Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Last-resort virus therapy takes on untreatable hip infection
Disease control Not yet recruitingThis study tests whether specially designed viruses (bacteriophages) can eliminate a persistent bacterial infection in a hip replacement joint. One adult who has failed all standard surgeries and antibiotics will receive the viruses directly into the joint and through an IV for t…
Phase: PHASE1, PHASE2 • Sponsor: University of Calgary • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New sepsis protocol aims to save lives by speeding up care
Disease control Not yet recruitingThis study will test whether a standardized set of emergency steps—including early screening, blood tests, fluids, and antibiotics—can improve survival for sepsis patients. Researchers will compare outcomes for 120 adults treated before and after the new protocol is introduced. T…
Phase: NA • Sponsor: Al-Azhar University • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New dental material could save more teeth from root canals
Disease control Not yet recruitingThis study tests a new material made from treated dentin and calcium silicate for treating deep cavities that have reached the tooth's nerve. The goal is to see if it can keep the nerve healthy better than the current standard material. Fifty-six people aged 14 to 35 with deep ca…
Phase: NA • Sponsor: All India Institute of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Can a vaginal bacteria capsule boost IVF success?
Disease control Not yet recruitingThis study tests a new treatment called FB301, a capsule containing beneficial bacteria, for women with an imbalance of vaginal bacteria who have had a failed frozen embryo transfer (IVF). Thirty women aged 18-40 will receive FB301 or a placebo during a mock IVF cycle, with some …
Phase: PHASE2 • Sponsor: Freya Biosciences ApS • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
Could a simple antibiotic combo save lives after heart valve surgery?
Disease control Not yet recruitingThis study will test whether giving an extra antibiotic during a heart valve replacement procedure (TAVI) can lower the chance of bloodstream infection or death within 6 months. About 2,000 patients in Denmark will take part. Half will get the standard antibiotic, and half will g…
Phase: NA • Sponsor: Rigshospitalet, Denmark • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
New drug duo takes on deadly brain infection
Disease control Not yet recruitingThis study tests a new two-drug combination (Alpibectir and Ethionamide) added to standard treatment for tuberculosis meningitis, a serious brain infection. About 64 adults newly diagnosed with the condition will receive the drugs to see how well they reach the brain and how safe…
Phase: PHASE2 • Sponsor: BioVersys AG • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Could steroids save your joints after a severe infection?
Disease control Not yet recruitingThis study tests whether adding a steroid (prednisone) to standard antibiotics can improve joint function in adults with septic arthritis, a serious joint infection. Two hundred participants will receive either prednisone or a placebo for 7 days. The main goal is to see if steroi…
Phase: PHASE2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
New weapon against superbug pneumonia and blood infections
Disease control Not yet recruitingThis study tests a new antibiotic combination (BV100 plus other drugs) against hard-to-treat infections like pneumonia and bloodstream infections caused by carbapenem-resistant Acinetobacter baumannii. About 120 adults in the hospital will receive either the new combo or the best…
Phase: PHASE2 • Sponsor: BioVersys AG • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Desperate times: phage cocktail takes on Drug-Resistant lung bug
Disease control Not yet recruitingThis early study tests a special cocktail of viruses (phages) designed to attack a drug-resistant bacterium causing chronic lung infection. Only one person will receive the treatment alongside their usual antibiotics. The goal is to see if it's safe and can reduce the amount of b…
Phase: PHASE1 • Sponsor: Alberta Health services • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Could a sweetener beat a gut infection? new trial explores xylitol for c. diff in IBD
Disease control Not yet recruitingThis study tests if xylitol, a common sweetener, can safely clear C. difficile bacteria from the gut in people with inflammatory bowel disease (IBD). About 99 adults with mild or inactive IBD will take either a low or high dose of xylitol or a placebo for four weeks. Researchers …
Phase: PHASE1 • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
New light treatment could zap stubborn eyelid lumps
Disease control Not yet recruitingThis study tests if intense pulsed light (IPL) is a safe and effective way to treat chalazion, a common eyelid lump. About 40 adults with an inflamed chalazion will receive IPL or a control treatment. The main goal is to see if the lump shrinks by at least 80% four weeks after th…
Phase: NA • Sponsor: Lumenis Be Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Could a simple pulpotomy replace root canals for some patients?
Disease control Not yet recruitingThis study compares two treatments for irreversible pulpitis, a condition causing severe tooth pain. The standard treatment is a root canal, but researchers want to see if a less invasive procedure called pulpotomy works just as well. The study will involve 138 people and also lo…
Phase: NA • Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Peer support could be key to beating TB in ethiopia
Disease control Not yet recruitingThis study tests whether a peer-led education program helps adults with drug-susceptible tuberculosis complete treatment successfully. Researchers in southern Ethiopia will enroll 250 adults and provide structured education, counseling, and follow-up from trained peers. The goal …
Phase: NA • Sponsor: Bahirdar University • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Can early combo therapy shield kidneys in septic shock?
Disease control Not yet recruitingThis study tests whether giving intravenous fluids and a blood-pressure-raising drug (norepinephrine) together early can prevent acute kidney injury in adults with septic shock. Researchers will treat 100 patients in the ICU or emergency department and monitor kidney function and…
Phase: NA • Sponsor: Universitas Sumatera Utara • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
New Tooth-Saving technique could spare teens from root canals
Disease control Not yet recruitingThis study tests if a less invasive procedure called partial pulpotomy using CGF (a blood concentrate) can control pain and inflammation in severely decayed permanent molars as well as standard root canal treatment. It will involve 60 adolescents aged 11-17 with intense tooth pai…
Phase: NA • Sponsor: Minia University • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Personalized antibiotic strategy aims to prevent deadly infections after kidney transplant
Disease control Not yet recruitingThis study tests whether giving a daily antibiotic (pivmecillinam) to kidney transplant patients at high risk of bloodstream infections can reduce those infections. 150 participants will receive either the antibiotic or a placebo for 5 months after transplant. The goal is to see …
Phase: PHASE2 • Sponsor: Susanne Dam Nielsen, MD, DMSc • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Stool test could shorten h. pylori treatment to just 7 days
Disease control Not yet recruitingThis study tests whether a 7-day course of antibiotics chosen by a stool test works as well as a 14-day course for people with stubborn H. pylori infections. About 290 adults who have failed previous treatment will get a stool test to find which drugs their infection resists, the…
Phase: PHASE4 • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Stool test may cut h. pylori treatment time in half
Disease control Not yet recruitingThis study tests whether a 7-day course of antibiotics, chosen based on a stool test, can clear H. pylori infection as effectively as a standard 14-day course. About 544 adults with a first-time H. pylori infection will provide a stool sample for drug-resistance testing and then …
Phase: PHASE4 • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
New pneumonia vaccine put to the test in babies
Disease control Not yet recruitingThis early-stage study tests a new pneumococcal vaccine (Pn-MAPS30plus) in 60 healthy infants to see if it is safe and what side effects it may cause. Babies will receive three doses starting around 2 months old, followed by a booster at 12-15 months. The study compares the new v…
Phase: PHASE1 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
New study tests best way to deliver antibiotics for sepsis
Disease control Not yet recruitingThis study looks at two methods of giving beta-lactam antibiotics to patients with sepsis or septic shock in the ICU: a slow 4-hour infusion versus a quick 30-minute infusion. Researchers will track survival at 90 days and whether the infection clears within 14 days. The goal is …
Sponsor: Assiut University • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
New study to test anthrax drug in bioterror attack scenario
Disease control Not yet recruitingThis study will evaluate how well the drug raxibacumab works and how safe it is for people who have symptoms of inhalational anthrax after a large-scale exposure, such as a bioterrorist attack. Up to 100 people of all ages, including pregnant women and children, who receive the d…
Phase: PHASE4 • Sponsor: Emergent BioSolutions • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Anthrax drug under the microscope: will it save lives?
Disease control Not yet recruitingThis study follows up to 10 people with severe anthrax who receive a treatment called AIGIV. Researchers will track how many patients survive and whether the drug causes serious side effects. The goal is to learn more about how well AIGIV works and how it behaves in the body.
Sponsor: Emergent BioSolutions • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Emergency anthrax drug trial set to launch if outbreak strikes
Disease control Not yet recruitingThis study will test a medicine called AIGIV for people who have breathed in anthrax germs during a large-scale emergency. The goal is to see if the drug helps more people survive and to check for side effects. The study will only start if a major anthrax event happens, and it wi…
Sponsor: Emergent BioSolutions • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Could a heart drug beat a deadly blood infection? new trial aims to find out
Disease control Not yet recruitingThis study tests whether adding clopidogrel, a drug usually used to prevent blood clots, to standard antibiotics improves outcomes for adults with a serious Staphylococcus aureus bloodstream infection. About 230 hospitalized patients will be randomly assigned to receive clopidogr…
Phase: PHASE2 • Sponsor: Fundación Pública Andaluza para la gestión de la Investigación en Sevilla • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
New hope against Drug-Resistant TB: phase II trial launches
Disease control Not yet recruitingThis study tests whether adding acetohydroxamic acid (AHA) to a short-course antibiotic regimen can safely and effectively treat multidrug-resistant tuberculosis (MDR-TB). About 120 adults with confirmed MDR-TB will receive either AHA or a placebo alongside standard drugs. The go…
Phase: PHASE2 • Sponsor: Shanghai Pulmonary Hospital, Shanghai, China • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Could a common antioxidant save newborns from deadly sepsis?
Disease control Not yet recruitingThis study tests whether adding N-acetylcysteine (NAC) to standard care helps newborns with sepsis. Sepsis causes dangerous inflammation and cell damage. NAC may reduce this damage by boosting the body's defenses. The trial will enroll 50 near-term and term infants to see if NAC …
Phase: PHASE3 • Sponsor: Ain Shams University • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Could a Rose-Scented oil replace standard fillings in Kids' cavities?
Disease control Not yet recruitingThis study looks at whether an essential oil from Pelargonium graveolens (a type of geranium) can be used to treat deep cavities in children's baby teeth. The goal is to see if it works as well as current materials to relieve pain and prevent infection. Thirty children will recei…
Phase: NA • Sponsor: Tanta University • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Virus cocktail takes on superbug UTIs in tiny new trial
Disease control Not yet recruitingThis early study tests whether a personalized mix of viruses (called phages) can safely treat urinary tract infections caused by drug-resistant bacteria. Six adults aged 18–65 will receive the phage cocktail through a catheter every 12 hours for 2–3 days. Researchers will monitor…
Phase: NA • Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Could a blood pressure cuff help fight septic shock?
Disease control Not yet recruitingThis study tests whether a non-invasive arm cuff procedure, called remote ischemic postconditioning, can reduce deaths in adults with septic shock. The cuff is inflated and deflated in cycles to briefly restrict blood flow, which may trigger protective effects. 720 ICU patients w…
Phase: NA • Sponsor: Hospices Civils de Lyon • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Double trouble for staph: could two antibiotics beat one?
Disease control Not yet recruitingThis study looks at whether using a combination of antibiotics is more effective than a single antibiotic for treating serious staph infections in the blood. About 2,096 adults with either methicillin-sensitive or methicillin-resistant staph will be randomly assigned to one group…
Phase: PHASE4 • Sponsor: Intermountain Health Care, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Could a 7-Day pill blast beat a 14-Day regimen for stomach bug?
Disease control Not yet recruitingThis study compares a 7-day high-dose vonoprazan-amoxicillin treatment to a standard 14-day regimen for eradicating H. pylori, a common stomach bacteria linked to ulcers and cancer. About 290 adults with confirmed infection will be randomly assigned to one of the two groups. The …
Phase: NA • Sponsor: Yueyue Li • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Could steroids save lives in severe parrot fever pneumonia?
Disease control Not yet recruitingThis study tests whether adding corticosteroids to standard antibiotic care can lower the risk of death in adults with severe psittacosis (parrot fever) pneumonia in the ICU. About 100 participants will receive either standard care alone or standard care plus different doses of s…
Phase: PHASE3 • Sponsor: Qingyuan Zhan • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Can a blood filter save lives in septic shock?
Disease control Not yet recruitingThis study tests a blood purification filter called Oxiris in adults with septic shock and organ failure. Researchers want to see if it lowers the risk of death or worsening organ function within 7 days. Participants will receive the filter treatment for up to 3 days in the ICU a…
Phase: NA • Sponsor: Pusan National University Yangsan Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
New hope for preterm labor: simple vaginal tablet may buy extra time for babies
Disease control Not yet recruitingThis study tests whether adding a vaginal tablet containing good bacteria and a low-dose hormone (Gynoflor®) to standard preterm labor treatment can help women stay pregnant longer. About 80 pregnant women between 24 and 33 weeks will receive either the tablet or a placebo for 6 …
Phase: NA • Sponsor: Queen Savang Vadhana Memorial Hospital, Thailand • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
New cocktail of charcoal and laxative could speed up poison recovery
Disease control Not yet recruitingThis study tests whether giving a combination of activated charcoal and polyethylene glycol (a laxative) can reduce the amount of toxic drugs absorbed in the gut for people with severe poisoning in intensive care. Two hundred adults on ventilators will be randomly assigned to get…
Phase: PHASE2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Can herbs and viruses beat Drug-Resistant pneumonia?
Disease control Not yet recruitingThis early-phase trial tests a Chinese herbal formula (Yiqi Huoxue Jiedu) combined with bacteriophages—viruses that target specific bacteria—in 240 people with severe pneumonia caused by drug-resistant germs. The goal is to see if the combination clears the infection faster and l…
Phase: EARLY_PHASE1 • Sponsor: Chinese PLA General Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
New surgery aims to rebuild hips in children after severe infection
Disease control Not yet recruitingThis study looks at the long-term results of a surgery that replaces the missing growth plate at the top of the thigh bone in children who lost it due to a severe hip infection. Researchers will check how well the bone heals and how well the hip works at least five years after th…
Sponsor: Assiut University • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
New scope surgery may improve outcomes for babies with meningitis complications
Disease control Not yet recruitingThis study will compare two surgical methods for treating fluid collections in the brain that can occur after infant meningitis. One method uses a small camera (neuroendoscope) to remove debris and place a reservoir for drainage. The other is a standard burr hole drainage. The tr…
Sponsor: Shengjing Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Ultrasound-Guided Beta-Blockers: a new hope for septic shock?
Disease control Not yet recruitingThis pilot study tests whether using ultrasound to guide treatment with the beta-blocker esmolol is feasible in patients with septic shock. Septic shock is a life-threatening condition where infection causes very low blood pressure and a dangerously fast heart rate. The trial wil…
Phase: PHASE1, PHASE2 • Sponsor: John Basmaji • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Old antibiotic gets a second look for tough e. coli infections
Disease control Not yet recruitingThis pilot study will test whether the antibiotic cefotetan works as well as standard treatments for E. coli infections in the blood or urinary tract. About 84 hospitalized adults will be randomly assigned to receive cefotetan or usual care. The goal is to see if cefotetan can su…
Phase: PHASE2 • Sponsor: Oregon Health and Science University • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
New study tests faster way to fix kids' tooth infections
Disease control Not yet recruitingThis study looks at two methods for cleaning and filling infected baby molars in children aged 5-7. One method uses a manual tool, the other a rotating tool. The goal is to see which works better over a year. About 44 children will take part.
Phase: NA • Sponsor: Anfal mohamed elmotaz almogtaba • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Texts and videos aim to boost TB prevention in ethiopia
Disease control Not yet recruitingThis study tests whether a digital health program—short videos and text message reminders—can help close contacts of tuberculosis patients start and complete preventive treatment. Researchers in South Ethiopia will enroll 304 people and compare those who get the digital intervent…
Phase: NA • Sponsor: Arba Minch University • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Can a different antibiotic beat stubborn pneumonia in kids?
Disease control Not yet recruitingThis study compares two antibiotics—doxycycline and azithromycin—in 208 children aged 3 to 17 with pneumonia caused by Mycoplasma pneumoniae. The goal is to see if doxycycline stops fever faster and is safe, especially regarding tooth color changes. Participants take the medicine…
Phase: PHASE4 • Sponsor: Young June Choe • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Can a cold blast save your tooth? new trial investigates cryotherapy for deep cavities
Disease control Not yet recruitingThis study looks at whether applying cold (cryotherapy) during a pulpotomy—a procedure that removes infected nerve tissue from a tooth—improves the chance of saving the tooth. Researchers will compare treatment success in 140 healthy adults with deep cavities. Success means no pa…
Phase: EARLY_PHASE1 • Sponsor: Sirawut Hiran-us • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
New bacterial vaginosis drug passes first safety check in healthy volunteers
Disease control Not yet recruitingThis early-stage trial tests a new drug called GenSci142 in 30 healthy Chinese women to see if it is safe and how the body processes it. Participants receive a single dose of the drug or a placebo, and are monitored for side effects for 15 days. The goal is to gather safety infor…
Phase: PHASE1 • Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Zinc and new acid reducer tested in h. pylori battle
Disease control Not yet recruitingThis phase 3 trial will test how well two different triple therapies—one using a standard acid reducer (proton pump inhibitor) and one using a newer drug (vonoprazan)—work to eliminate H. pylori infection. It will also see if adding zinc improves results. The study plans to enrol…
Phase: PHASE3 • Sponsor: Tanta University • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Dentists test two ways to save teeth with deep cavities
Disease control Not yet recruitingThis study compares two dental treatments for teeth with deep cavities and reversible pulpitis (early nerve inflammation). One treatment caps the exposed nerve directly, while the other removes a small part of the nerve before capping. The study will include 138 people aged 15-40…
Phase: NA • Sponsor: Postgraduate Institute of Dental Sciences Rohtak • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Lung valves could starve Drug-Resistant TB cavities
Disease control Not yet recruitingThis study tests whether placing one-way valves in the lungs can shrink cavities caused by drug-resistant tuberculosis (TB) or nontuberculous mycobacteria (NTM) infections. The valves block airflow into the cavity, creating a low-oxygen environment that may slow or stop bacterial…
Phase: NA • Sponsor: Azienda Ospedaliero-Universitaria Careggi • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Could a sweetener beat a gut infection? early trial tests xylitol for c. diff in IBD patients
Disease control Not yet recruitingThis pilot study tests whether xylitol, a common sugar alcohol, can safely clear C. difficile bacteria from the guts of people with inflammatory bowel disease (IBD). About 69 adults with mild or inactive IBD will take different doses of xylitol for up to 8 weeks. Researchers will…
Phase: EARLY_PHASE1 • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Stomach bug treatment may relieve chronic gut discomfort
Disease control Not yet recruitingThis study will test whether standard treatment to eliminate H. pylori bacteria can improve ongoing stomach and gut symptoms in 100 adults. Participants will receive antibiotics and acid-reducing medication, and their symptoms will be tracked using a questionnaire. The goal is to…
Sponsor: Amany Usama Ahmed Arafa • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Virus cocktail takes on superbugs in cystic fibrosis trial
Disease control Not yet recruitingThis early-stage study tests whether adding specially-made viruses (phages) to standard antibiotics can safely treat stubborn lung infections in adults with cystic fibrosis. About 30 participants will receive a 7-day course of both treatments. The main goal is to check safety, bu…
Phase: PHASE1 • Sponsor: University of California, San Diego • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New study aims to protect pregnant women with HIV from deadly TB
Disease control Not yet recruitingThis study will test two ways to find TB in pregnant women with HIV: using symptoms or a blood test. It will also compare starting TB prevention medicine right away versus after giving birth. The goal is to reduce harm to mothers and babies. About 1,500 pregnant women in Uganda w…
Phase: NA • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New 9-Month pill regimen could tackle Drug-Resistant TB
Disease control Not yet recruitingThis phase 3 trial tests a 9-month, all-oral combination of four drugs (BLMZ) for people aged 12 and older with rifampicin-resistant tuberculosis. The goal is to see if this shorter regimen leads to a cure without the need for injections. Participants take the pills daily or week…
Phase: PHASE3 • Sponsor: Beijing Chest Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
Blood level monitoring could speed sepsis recovery
Disease control Not yet recruitingThis study tests whether adjusting beta-lactam antibiotics based on blood levels helps critically ill sepsis patients recover faster. 198 adults in the ICU will be randomly assigned to either standard dosing or dosing guided by regular blood tests. The goal is to see if personali…
Phase: NA • Sponsor: Complexo Hospitalario Universitario de A Coruña • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
New study tests simpler tooth treatment for Kids' cavities
Disease control Not yet recruitingThis study compares two dental procedures for treating deep cavities in baby molars of children aged 6-8. One group gets a partial nerve treatment (pulpotomy) using a special cement, while the other gets a full root canal (pulpectomy) with a medicated paste. Researchers will trac…
Phase: NA • Sponsor: Cairo University • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Olive oil tooth treatment tested in kids
Disease control Not yet recruitingThis study tests a new root canal filling made from zinc oxide and ozonated olive oil against a standard material called Metapex in children aged 3-5 with cavities in their front teeth. Over 12 months, researchers will check for pain, swelling, and healing on X-rays. The goal is …
Phase: NA • Sponsor: Cairo University • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Double antibiotic attack: could a combo therapy beat strep in the blood?
Disease control Not yet recruitingThis study compares standard beta-lactam antibiotics alone versus beta-lactam plus levofloxacin in adults with streptococcal bacteremia (bacteria in the blood). 165 participants will be randomly assigned to receive either the combination or monotherapy. The goal is to see if addi…
Phase: PHASE4 • Sponsor: Mahidol University • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
New drug combo aims to simplify stomach infection treatment
Disease control Not yet recruitingThis study tests two ways of taking amoxicillin with tegoprazan to treat H. pylori, a stomach infection that can cause ulcers. About 240 adults will take the same total daily dose of antibiotics, but one group takes it three times a day and the other twice a day. The goal is to s…
Phase: PHASE4 • Sponsor: First People's Hospital of Hangzhou • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
New study could simplify Tooth-Saving treatment for kids
Disease control Not yet recruitingThis study compares two dental procedures for treating infected baby molars in children aged 4 to 8. One method removes only the infected part of the tooth's nerve (pulpotomy), while the other removes the entire nerve (pulpectomy). The goal is to see if the simpler pulpotomy work…
Phase: NA • Sponsor: Ajman University • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Can a blood protein boost survival in septic shock?
Disease control Not yet recruitingThis study tests whether giving extra human albumin—a natural blood protein—along with standard care can help people survive septic shock after surgery. Septic shock is a life-threatening condition where infection causes dangerously low blood pressure. The trial will enroll 304 a…
Phase: PHASE3 • Sponsor: Mahidol University • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Texting your doctor: a simple app could save lives after lung screening
Disease control Not yet recruitingThis study tests whether using a chat-based mobile app (Zalo) can help people follow through with recommended tests after an abnormal chest X-ray read by AI. About 2,692 adults in Vietnam at risk for lung cancer or TB will be randomly assigned to receive either standard results o…
Phase: NA • Sponsor: Gia Dinh People Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
New hope for IBD patients: can a better antibiotic stop c. diff for good?
Disease control Not yet recruitingThis study compares two antibiotics, fidaxomicin and vancomycin, to see which one is better at clearing C. difficile bacteria from the gut in people with inflammatory bowel disease (IBD). About 60 adults with IBD will take one of the two antibiotics for 10 days and be followed fo…
Phase: PHASE4 • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Can a japanese ARDS drug fix deadly clots in septic shock?
Disease control Not yet recruitingThis study tests whether sivelestat, a drug used in Japan for lung injury, can help restore the body's ability to break down harmful blood clots in people with septic shock. About 120 adults with septic shock and early blood clotting problems will receive either sivelestat or a p…
Phase: PHASE2 • Sponsor: University Hospital, Strasbourg, France • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Ancient herbs take on superbug pneumonia in new clinical trial
Disease control Not yet recruitingThis study tests whether adding a traditional Chinese medicine formula, Feireqing Granules, to standard care can improve survival in people with severe pneumonia caused by multidrug-resistant Gram-negative bacteria. The trial will enroll 152 adults and measure death rates at 14 a…
Phase: NA • Sponsor: Henan University of Traditional Chinese Medicine • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Could a 6-Month pill combo beat Drug-Resistant TB?
Disease control Not yet recruitingThis study tests whether a 6-month combination of four drugs (bedaquiline, delamanid, linezolid, and levofloxacin) works as well as the standard longer treatment for drug-resistant tuberculosis. Fifty-two adults in Hubei, China will be randomly assigned to either the short or sta…
Phase: NA • Sponsor: Wuhan Pulmonary Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
New study tests which cavity removal method saves more teeth
Disease control Not yet recruitingThis study compares two cavity removal methods in 144 adults with deep cavities and reversible pulpitis (tooth nerve inflammation that can heal). One method removes all decay, the other leaves some near the nerve. Researchers will check pain, tooth vitality, and X-rays over 12 mo…
Phase: NA • Sponsor: Minia University • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New 6-Month TB drug combo tested in diabetic patients
Disease control Not yet recruitingThis study tests a 6-month treatment regimen containing pretomanid for people with drug-resistant tuberculosis who also have type 2 diabetes. Researchers will compare how well the treatment works and how safe it is in diabetic patients versus non-diabetic patients. The goal is to…
Sponsor: Wuhan Pulmonary Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Could eggshells save your teeth? new trial tests natural pulp capping agent
Disease control Not yet recruitingThis study compares a new material made from eggshells (calcium hydroxyapatite) to a standard one (calcium hydroxide) for protecting the nerve in deep cavities. Fifty-four adults with reversible pulpitis will receive one of the two materials after cavity cleaning. Researchers wil…
Phase: NA • Sponsor: University of Health Sciences Lahore • Aim: Disease control
Last updated Jun 26, 2026 19:04 UTC
-
Could a simple dental procedure replace root canals?
Disease control Not yet recruitingThis study tests whether a less invasive dental procedure called full pulpotomy can heal infected molars as well as root canals. Researchers will treat 128 adults with deep cavities and compare healing in teeth with and without infection at the root tip. If successful, it may off…
Phase: NA • Sponsor: Postgraduate Institute of Dental Sciences Rohtak • Aim: Disease control
Last updated Jun 26, 2026 17:44 UTC
-
Can pressurized oxygen beat Flesh-Eating bacteria?
Disease control Not yet recruitingThis study will test whether adding hyperbaric oxygen therapy to standard care helps people with necrotizing fasciitis, a severe flesh-eating infection. Researchers will compare death rates and complications in 160 adults who receive the treatment versus historical controls. The …
Phase: NA • Sponsor: Corewell Health West • Aim: Disease control
Last updated Jun 26, 2026 16:39 UTC
-
Could a shorter TB course work for those with unclear test results?
Disease control Not yet recruitingThis study looks at people who have TB-like changes on chest X-rays but negative sputum tests. It compares different treatment lengths (8 to 24 weeks) versus close monitoring without immediate treatment. The goal is to find the shortest effective treatment and understand who real…
Phase: PHASE3 • Sponsor: University College, London • Aim: Disease control
Last updated Jun 26, 2026 14:37 UTC
-
Could a herbal granule help treat stomach infection and fatty liver together?
Disease control Not yet recruitingThis study tests whether adding a traditional Chinese medicine granule (Huazhi Rougan) to standard antibiotics can better treat both H. pylori infection and metabolic-associated fatty liver disease (MASH). About 286 adults with both conditions will receive either the herbal granu…
Phase: NA • Sponsor: Nanjing First Hospital, Nanjing Medical University • Aim: Disease control
Last updated Jun 26, 2026 14:29 UTC
-
Simple test could slash use of Last-Resort antibiotics for UTIs
Diagnosis Not yet recruitingThis trial investigates whether a rapid test for antibiotic resistance genes (integrons) can help doctors choose narrower-spectrum antibiotics for hospitalized adults with urinary tract infections (UTIs). Participants must have had a recent infection with a resistant bacterium. T…
Phase: NA • Sponsor: University Hospital, Limoges • Aim: Diagnosis
Last updated Jul 03, 2026 00:00 UTC
-
New blood test could spot sepsis in newborns faster
Diagnosis Not yet recruitingThis study will test a new biomarker called t6A to see if it can help doctors diagnose bacterial infections in newborn babies early. Researchers will measure t6A levels in 210 infants who need blood tests for suspected infection. The goal is to find a more accurate way to detect …
Sponsor: Salzburger Landeskliniken • Aim: Diagnosis
Last updated Jun 28, 2026 00:00 UTC
-
New bedside test could help doctors fine-tune antibiotics in real time
Diagnosis Not yet recruitingThis study will test a new, fast method to measure levels of beta-lactam antibiotics in the blood of intensive care patients. Researchers will compare the new method with standard lab tests using daily blood samples from 200 patients. The goal is to develop a point-of-care tool t…
Sponsor: Dr. T. Perl • Aim: Diagnosis
Last updated Jun 27, 2026 14:02 UTC
-
Quick blood tests could save newborns from sepsis
Diagnosis Not yet recruitingThis study explores whether routine blood tests—like CBC and lactate levels—can help doctors diagnose sepsis in newborns more quickly than waiting 2-3 days for a blood culture. Researchers will enroll 80 infants in the NICU with signs of infection and compare these rapid test res…
Sponsor: Assiut University • Aim: Diagnosis
Last updated Jun 27, 2026 14:02 UTC
-
AI stethoscope aims to cut unnecessary antibiotics in kids with cough
Diagnosis Not yet recruitingThis study tests whether an AI-powered digital stethoscope can help health workers more accurately diagnose pneumonia in children aged 2 months to 5 years. 350 children with cough or breathing difficulty will be randomly assigned to standard care or care plus the AI stethoscope. …
Phase: PHASE4 • Sponsor: Johns Hopkins University • Aim: Diagnosis
Last updated Jun 27, 2026 13:05 UTC
-
AI blood test could spot deadly clotting complication in sepsis patients
Diagnosis Not yet recruitingThis study aims to validate a new blood test that uses artificial intelligence to detect disseminated intravascular coagulation (DIC) early in patients with septic shock. DIC is a severe clotting disorder that often leads to death, but current diagnostic methods are complex and r…
Sponsor: University Hospital, Strasbourg, France • Aim: Diagnosis
Last updated Jun 27, 2026 13:03 UTC
-
New heart monitor tested in septic shock patients
Diagnosis Not yet recruitingThis study will test whether a new, continuous method of measuring heart function (using pressure waves) matches the current standard method (thermodilution) in 43 ICU patients with septic shock. Both methods use the same catheter already placed for treatment. The goal is to see …
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Diagnosis
Last updated Jun 27, 2026 13:03 UTC
-
Fast new swab test could speed up vaginitis diagnosis
Diagnosis Not yet recruitingThis study will test a new diagnostic device called the Nanopath assay, which aims to quickly detect bacteria or yeast causing vaginitis. Up to 1000 women with symptoms like itching or discharge will provide vaginal swab samples, either collected by a clinician or themselves. The…
Sponsor: Nanopath, Inc • Aim: Diagnosis
Last updated Jun 27, 2026 12:37 UTC
-
Can a simple blood test spot hidden heart trouble during High-Pressure oxygen treatment?
Diagnosis Not yet recruitingThis study looks at whether a blood gas measurement (the difference in carbon dioxide between central venous and arterial blood) can accurately diagnose low cardiac output in patients with septic shock from severe skin infections. About 74 adults will be monitored during hyperbar…
Sponsor: University Hospital, Lille • Aim: Diagnosis
Last updated Jun 27, 2026 12:33 UTC
-
One-Hour test could revolutionize pneumonia treatment in hospitals
Diagnosis Not yet recruitingThis study compares a rapid test that identifies pneumonia-causing bacteria in about one hour to standard lab methods that take 2-4 days. Researchers want to see if the faster test helps doctors choose the right antibiotics sooner for 150 hospitalized patients with pneumonia. The…
Phase: NA • Sponsor: Hospital de Clinicas de Porto Alegre • Aim: Diagnosis
Last updated Jun 27, 2026 12:33 UTC
-
One fingerstick, three infections: new rapid test under study
Diagnosis Not yet recruitingThis study will test a new rapid device called TruPlex that checks for HIV, Hepatitis B, and Syphilis using a single fingerstick blood sample. About 500 adults at risk for these infections will take part. Researchers want to see if the test is accurate and easy for trained staff …
Phase: NA • Sponsor: bioLytical Laboratories • Aim: Diagnosis
Last updated Jun 27, 2026 12:29 UTC
-
Sputum DNA test aims to outsmart Drug-Resistant TB
Diagnosis Not yet recruitingThis trial tests a new DNA test that reads drug resistance directly from sputum samples in people with multidrug-resistant tuberculosis (MDR-TB). The goal is to see if this test helps doctors prescribe at least five effective drugs within 14 days of diagnosis, compared to current…
Phase: NA • Sponsor: University of Cape Town • Aim: Diagnosis
Last updated Jun 27, 2026 12:29 UTC
-
New rapid STI test aims to cut treatment wait times
Diagnosis Not yet recruitingThis study will test whether a fast, point-of-care test for chlamydia and gonorrhea can reduce the time it takes for people to start antibiotics. Four hundred asymptomatic adults visiting a sexual health clinic will be randomly assigned to receive either the rapid test or a stand…
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 12:08 UTC
-
Quick ER test could spot HIV and syphilis in pregnant women, saving babies
Diagnosis Not yet recruitingThis study will test a rapid fingerstick test for HIV and syphilis in pregnant women who come to the emergency department without prior prenatal care. Researchers want to see if offering this test leads to more women being diagnosed and starting treatment right away. The goal is …
Phase: NA • Sponsor: The University of Texas Health Science Center, Houston • Aim: Diagnosis
Last updated Jun 27, 2026 12:06 UTC
-
Could a tongue swab replace sputum tests for TB?
Diagnosis Not yet recruitingThis large study in five countries will test new, portable diagnostic tools for tuberculosis (TB) that use tongue swabs and AI-assisted chest X-rays. The goal is to see if these faster, easier tests can find more TB cases, especially in people who have no symptoms or can't produc…
Phase: NA • Sponsor: Liverpool School of Tropical Medicine • Aim: Diagnosis
Last updated Jun 27, 2026 12:05 UTC
-
Blood oxygen test may guide fluid therapy in sepsis
Diagnosis Not yet recruitingThis study looks at whether measuring oxygen levels in a central vein can help doctors decide if a patient with septic shock needs more fluids. About 115 adults with septic shock will have their oxygen levels checked before and after a fluid challenge. The results will be compare…
Sponsor: Menoufia University • Aim: Diagnosis
Last updated Jun 27, 2026 12:04 UTC
-
AI app aims to help frontline workers diagnose neglected skin diseases
Diagnosis Not yet recruitingThis study tests whether a mobile app using artificial intelligence can help frontline health workers in sub-Saharan Africa better diagnose skin-related neglected tropical diseases, like leprosy and scabies. Researchers will collect images from dermatologists to train the AI, the…
Phase: NA • Sponsor: Kenya Medical Research Institute • Aim: Diagnosis
Last updated Jun 27, 2026 12:04 UTC
-
New plague test could speed up diagnosis in remote congo
Diagnosis Not yet recruitingThis study will test a new rapid diagnostic test for plague in the Ituri province of DR Congo. Researchers will collect samples like blood, saliva, and bubo fluid from 300 people with suspected plague to see how well the new test works compared to standard lab methods. The goal i…
Sponsor: Institute of Tropical Medicine, Belgium • Aim: Diagnosis
Last updated Jun 27, 2026 12:01 UTC
-
Quick syphilis test at family planning visits studied in Hawai'i
Diagnosis Not yet recruitingThis study looks at whether offering a rapid syphilis test during family planning visits (for birth control or abortion) is practical and acceptable to patients. About 70 participants will get a fingerstick test with results in 10-15 minutes, instead of waiting days. The goal is …
Sponsor: Queen's Medical Center • Aim: Diagnosis
Last updated Jun 27, 2026 11:02 UTC
-
Tooth blood test could end guesswork in root canal decisions
Diagnosis Not yet recruitingThis study looks at whether two substances in the blood of a tooth's pulp—IL-8 and presepsin—can help dentists tell the difference between a tooth infection that can heal on its own and one that needs a root canal. Researchers will collect pulp blood samples from 50 patients with…
Sponsor: Cairo University • Aim: Diagnosis
Last updated Jun 27, 2026 11:00 UTC
-
New lung biopsy technique could spot TB faster and safer
Diagnosis Not yet recruitingThis trial tests a new biopsy method called EBUS-TBMC against the standard needle approach for diagnosing tuberculosis in chest lymph nodes. About 108 adults with suspected TB will undergo both procedures in one session to see which yields better tissue samples. The goal is to im…
Phase: NA • Sponsor: China-Japan Friendship Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 11:00 UTC
-
Spit test could replace needles for tetanus check
Diagnosis Not yet recruitingThis study aims to create a quick, non-invasive test using saliva to see if someone has enough antibodies to fight tetanus. Instead of drawing blood, a small saliva sample on a test strip would give results in 10-15 minutes. The test is designed for low- and middle-income areas w…
Phase: NA • Sponsor: University of Birmingham • Aim: Diagnosis
Last updated Jun 27, 2026 09:09 UTC
-
Rapid brain infection test could slash unnecessary antibiotic use
Diagnosis Not yet recruitingThis study looks at whether a quick diagnostic test (BioFire FilmArray) can accurately predict the cause of meningitis or encephalitis in 182 adults. Participants with symptoms like fever, headache, or confusion will have their spinal fluid tested. The goal is to see if the test …
Phase: NA • Sponsor: Federal University of Health Science of Porto Alegre • Aim: Diagnosis
Last updated Jun 27, 2026 09:08 UTC
-
New rapid swab test could transform TB diagnosis in remote areas
Diagnosis Not yet recruitingThis study will test a new, portable device that can detect tuberculosis (TB) in about 15-35 minutes using a simple tongue or sputum swab. It aims to enroll 60,000 people in Bangladesh, Cameroon, and Nigeria who are screened in community settings. The goal is to see if this rapid…
Phase: NA • Sponsor: Liverpool School of Tropical Medicine • Aim: Diagnosis
Last updated Jun 27, 2026 09:06 UTC
-
New TB tests aim to find more cases in indonesia
Diagnosis Not yet recruitingThis study tests whether new, easier-to-use diagnostic tests for tuberculosis (TB) can help find more cases in Indonesia. About 40,000 people with TB symptoms will take part. Some clinics will use the new tests, while others will use standard methods. The goal is to see if the ne…
Phase: NA • Sponsor: Universitas Padjadjaran • Aim: Diagnosis
Last updated Jun 27, 2026 09:03 UTC
-
New All-in-One test could save thousands of babies from infections
Diagnosis Not yet recruitingThis study will check if a new device called MagIA H3S can accurately detect HIV, hepatitis B, hepatitis C, and syphilis in pregnant women in the Democratic Republic of the Congo. About 7,500 pregnant women will take part. The goal is to see if this quick test works as well as st…
Sponsor: Gardiens de Vies • Aim: Diagnosis
Last updated Jun 27, 2026 09:02 UTC
-
Breath sniff test could spot COVID and flu in hospital patients
Diagnosis Not yet recruitingThis study tests whether analyzing chemicals in a person's breath can quickly identify serious respiratory infections like COVID-19, flu, and Legionella in hospitalized patients. Researchers will collect breath samples from 777 adults using a simple bag, then analyze them in a la…
Phase: NA • Sponsor: Hospices Civils de Lyon • Aim: Diagnosis
Last updated Jun 27, 2026 08:12 UTC
-
New test could speed up diagnosis of Tick-Borne disease
Diagnosis Not yet recruitingThis study will test a new RT-PCR method to diagnose Rickettsia infection, a tick-borne disease, using routine biopsy samples. Researchers will enroll 800 patients with suspected infection and compare the new test to standard methods. The goal is to see if the test can detect the…
Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna • Aim: Diagnosis
Last updated Jun 27, 2026 08:07 UTC
-
Simple fluid test could replace needle biopsy for TB of the lung lining
Diagnosis Not yet recruitingThis study tests a new liquid biopsy that measures TB DNA in fluid from around the lungs to diagnose tuberculous pleuritis, a common form of TB. Current methods often require invasive tissue biopsies or have low accuracy. The trial will enroll 350 adults with new-onset pleural ef…
Sponsor: Chinese University of Hong Kong • Aim: Diagnosis
Last updated Jun 27, 2026 08:04 UTC
-
New TB tests for kids could save thousands of lives
Diagnosis Not yet recruitingThis study aims to find better ways to diagnose tuberculosis (TB) in children and young teens. It will test new tools like computer-aided chest X-ray reading and non-sputum samples (e.g., stool or urine) in Bangladesh, Cameroon, Kenya, and Vietnam. About 7,920 participants aged 1…
Phase: NA • Sponsor: Liverpool School of Tropical Medicine • Aim: Diagnosis
Last updated Jun 27, 2026 07:59 UTC
-
Blood test could spare thousands from invasive TB diagnosis
Diagnosis Not yet recruitingThis study tests a new blood test that looks for TB DNA in the blood. It aims to see if it works as well as a bronchoscopy (a scope down the throat) to diagnose lung tuberculosis. 600 adults who need a bronchoscopy will give a blood sample for comparison. If successful, patients …
Sponsor: Chinese University of Hong Kong • Aim: Diagnosis
Last updated Jun 27, 2026 07:58 UTC
-
Simple urine test could spot pneumonia in kids without needles
Diagnosis Not yet recruitingThis study will test whether a new urine-based test can accurately diagnose pneumococcal pneumonia in children under 5 in Malawi. Researchers will use 350 stored urine samples from healthy kids and those with pneumonia, comparing results to standard lab methods. If it works, this…
Sponsor: Liverpool School of Tropical Medicine • Aim: Diagnosis
Last updated Jun 26, 2026 18:04 UTC
-
New 10-Minute syphilis test could save mothers and babies in uganda
Diagnosis Not yet recruitingSyphilis affects about 1 in 25 pregnant women in Uganda and can harm both mother and baby if untreated. This study will test a new rapid test that gives results in 10 minutes, comparing it to standard lab tests that take hours or days. Researchers will enroll 24 mothers and their…
Sponsor: St George's, University of London • Aim: Diagnosis
Last updated Jun 26, 2026 17:22 UTC
-
Could One-Time TB pill delivery stop the spread?
Prevention Not yet recruitingThis study tests a simpler way to give TB preventive therapy to household contacts of TB patients and people living with HIV. Instead of monthly clinic visits, some participants get the full course of pills at once in their community. Researchers want to see if this approach help…
Phase: NA • Sponsor: University of Washington • Aim: Prevention
Last updated Jul 02, 2026 00:00 UTC
-
Text message nudge could save thousands from pneumonia
Prevention Not yet recruitingThis study tests whether a simple WhatsApp message reminding people turning 65 in Chile to get their free pneumococcal vaccine can increase vaccination rates. Over 43,000 adults will be randomly assigned to receive the reminder or not, and researchers will track who gets vaccinat…
Phase: NA • Sponsor: Pablo Tomás Valenzuela García • Aim: Prevention
Last updated Jun 27, 2026 14:01 UTC
-
New daily pill could shield kids from TB
Prevention Not yet recruitingThis study tests a 28-day daily combination of two drugs, rifapentine and isoniazid, to prevent tuberculosis (TB) in children under 13. About 144 children, some with HIV and some without, will join to find the right dose and check for side effects. The goal is to see if this shor…
Phase: PHASE1, PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Prevention
Last updated Jun 27, 2026 13:07 UTC
-
Can a simple vaccine keep COPD patients out of the hospital?
Prevention Not yet recruitingThis large trial will study whether flu and pneumonia vaccines can reduce serious flare-ups and medical costs in people aged 45-80 with COPD. About 7,000 participants will be split into four groups: flu vaccine, pneumonia vaccine, both, or no vaccine. Researchers will track lung …
Phase: PHASE4 • Sponsor: Jiangsu Province Centers for Disease Control and Prevention • Aim: Prevention
Last updated Jun 27, 2026 13:07 UTC
-
New shot aims to block deadly tetanus after dirty wounds
Prevention Not yet recruitingThis study tests a new medicine called SNA02-48 to see if it can prevent tetanus in people who have had a high-risk wound, like a deep cut or puncture from a dirty object. About 600 adults will receive either the new injection or the standard treatment (human tetanus immunoglobul…
Phase: PHASE3 • Sponsor: Sinovac Life Sciences Co., Ltd. • Aim: Prevention
Last updated Jun 27, 2026 13:04 UTC
-
One shot in pregnancy could shield babies from whooping cough
Prevention Not yet recruitingThis phase 3 trial will give a single dose of the dTpa vaccine (Boostrix) to 95 healthy Japanese pregnant women between 27 and 37 weeks of pregnancy. The goal is to see if the vaccine triggers strong immunity in the mothers and passes protective antibodies to their babies at birt…
Phase: PHASE3 • Sponsor: GlaxoSmithKline • Aim: Prevention
Last updated Jun 27, 2026 12:36 UTC
-
Which vaccine schedule works best? new study aims to protect babies from pneumococcal disease
Prevention Not yet recruitingThis study compares two schedules (2+1 vs 3+1 doses) of a 13-valent pneumococcal vaccine in 210 healthy infants starting at 2 months old. Researchers will measure antibody levels and track side effects to find the best way to prevent pneumococcal infections.
Phase: NA • Sponsor: Beijing Center for Disease Control and Prevention • Aim: Prevention
Last updated Jun 27, 2026 12:32 UTC
-
Newborn infection shield: taurolidine lock tested in 576 babies
Prevention Not yet recruitingThis study tests whether a taurolidine lock solution, placed inside central catheters, can prevent bloodstream infections in newborns. About 576 infants with central lines will receive either the taurolidine lock or a saline lock every 48 hours. The goal is to see if this approac…
Phase: NA • Sponsor: University of Turin, Italy • Aim: Prevention
Last updated Jun 27, 2026 12:32 UTC
-
Could a common steroid prevent a deadly complication in AIDS patients?
Prevention Not yet recruitingThis study tests whether a short course of the steroid prednisolone can prevent paradoxical immune reconstitution inflammatory syndrome (IRIS) in people with AIDS who have low CD4 counts and are starting HIV treatment. About 131 participants will receive either prednisolone or no…
Phase: NA • Sponsor: Shanghai Public Health Clinical Center • Aim: Prevention
Last updated Jun 27, 2026 12:29 UTC
-
Bile acid breakthrough: could a Decades-Old pill stop c. diff in its tracks?
Prevention Not yet recruitingThis early-phase trial tests whether adding Ursodeoxycholic Acid (UDCA) to standard antibiotics can prevent Clostridioides difficile (C. diff) infection from returning. About 30 adults with C. diff and risk factors for recurrence will take UDCA three times daily for up to eight w…
Phase: EARLY_PHASE1 • Sponsor: Medical College of Wisconsin • Aim: Prevention
Last updated Jun 27, 2026 12:25 UTC
-
Prison TB study aims to stop spread with new screening methods
Prevention Not yet recruitingThis study compares three different ways to screen for and prevent tuberculosis (TB) in prisons in Paraguay. About 4,500 inmates will be tested and followed for 18 months to see which strategy best reduces new TB cases and infections. The goal is to find a safe, effective, and af…
Phase: NA • Sponsor: Universidad Nacional de Caaguazu • Aim: Prevention
Last updated Jun 27, 2026 12:08 UTC
-
Simple infusion may keep blood pressure stable during emergency surgery
Prevention Not yet recruitingThis study tests if giving a low-dose norepinephrine drip just before anesthesia can prevent low blood pressure during emergency surgery for a serious belly infection (peritonitis). About 60 adults with stable blood pressure after initial treatment will be randomly assigned to re…
Phase: PHASE4 • Sponsor: Bach Mai Hospital • Aim: Prevention
Last updated Jun 27, 2026 12:08 UTC
-
Health workers on doorsteps: a new push to stop TB in kids
Prevention Not yet recruitingThis study tests whether having health workers visit homes can improve tuberculosis (TB) prevention for children under 15 in southern Ethiopia. About 1,300 children will be split into two groups: one gets home-based care, the other standard clinic care. The goal is to see if more…
Phase: NA • Sponsor: Dilla University • Aim: Prevention
Last updated Jun 27, 2026 11:03 UTC
-
New combo pill aims to end recurring vaginal infections
Prevention Not yet recruitingThis study tests whether BPR-101 capsules, taken with the antibiotic metronidazole, can prevent bacterial vaginosis (BV) from coming back. Eighty women with BV will receive either the active treatment or a placebo. The main goal is to see if the combination lowers the rate of BV …
Phase: PHASE2 • Sponsor: Chengdu Syncor Pharmaceutical Co., Ltd. • Aim: Prevention
Last updated Jun 27, 2026 11:02 UTC
-
New shot aims to block tetanus after cuts and wounds
Prevention Not yet recruitingThis study tests a new medicine called siltartoxatug to prevent tetanus in people who have been injured. About 6,000 adults in China will receive either the new drug or a standard tetanus shot. Researchers will check how well each treatment prevents tetanus over 90 days and monit…
Sponsor: Zhuhai Trinomab Pharmaceutical Co., Ltd. • Aim: Prevention
Last updated Jun 27, 2026 08:11 UTC
-
Don't wash that baby! study tests if keeping vernix on prevents eczema
Prevention Not yet recruitingThis study tests whether leaving the white, creamy coating (vernix caseosa) on a newborn's skin for at least 24 hours after birth can prevent eczema (atopic dermatitis) during the first year of life. Over 1,300 mother-infant pairs in Chile will be randomly assigned to either keep…
Phase: NA • Sponsor: Pontificia Universidad Catolica de Chile • Aim: Prevention
Last updated Jun 27, 2026 08:10 UTC
-
Old drug, new trick: vancomycin may stop c. diff before it starts
Prevention Not yet recruitingThis study tests whether taking oral vancomycin alongside other antibiotics can prevent Clostridioides difficile infection (C. diff) in people aged 65 and older. Participants are randomly assigned to receive either vancomycin or standard care. The goal is to see if the drug reduc…
Phase: PHASE2, PHASE3 • Sponsor: University of Maryland, Baltimore • Aim: Prevention
Last updated Jun 27, 2026 08:08 UTC
-
New anthrax vaccine under review for Post-Exposure protection
Prevention Not yet recruitingThis study will look at 250 people who received the CYFENDUS anthrax vaccine after being exposed to anthrax bacteria during a mass event. Researchers want to see if the vaccine, given along with antibiotics, can prevent inhalational anthrax and anthrax meningitis. The study is ob…
Sponsor: Emergent BioSolutions • Aim: Prevention
Last updated Jun 27, 2026 08:03 UTC
-
Probiotic drops may stop antibiotic tummy troubles in children
Prevention Not yet recruitingThis study tests whether a probiotic supplement in oral drops can prevent diarrhea in children aged 0-12 who are taking common antibiotics like amoxicillin. One thousand children will receive either the probiotic or a placebo during their antibiotic course, and researchers will t…
Phase: NA • Sponsor: Liaquat University of Medical & Health Sciences • Aim: Prevention
Last updated Jun 27, 2026 07:59 UTC
-
Could a cold rinse during root canals ease Post-Procedure pain?
Symptom relief Not yet recruitingThis study tests whether using very cold water (around 2-3°C) to rinse the inside of a tooth during a root canal can lower pain afterward. The trial includes adults aged 20-40 with painful, infected lower molars. Participants are randomly assigned to receive either cold rinses th…
Phase: NA • Sponsor: Cairo University • Aim: Symptom relief
Last updated Jul 02, 2026 00:00 UTC
-
Could a common painkiller speed up cellulitis recovery?
Symptom relief Not yet recruitingCellulitis is a painful bacterial skin infection. This study tests whether adding naproxen (an anti-inflammatory drug) to standard antibiotics helps reduce redness and pain faster than antibiotics alone. About 884 adults with cellulitis will take either naproxen or a placebo for …
Phase: PHASE3 • Sponsor: Ottawa Hospital Research Institute • Aim: Symptom relief
Last updated Jun 27, 2026 14:03 UTC
-
Chill after the drill: could cold saline soothe root canal pain?
Symptom relief Not yet recruitingThis study looks at whether using a cold saline rinse after ultrasonic cleaning during a root canal can lower pain afterward. Adults with an inflamed tooth nerve will get either ultrasonic cleaning alone or followed by a cold saline flush. Pain levels are tracked for three days a…
Phase: NA • Sponsor: Dr Arsalan Ali Khan • Aim: Symptom relief
Last updated Jun 27, 2026 14:02 UTC
-
Keto diet tested to fight muscle loss in hospitalized pneumonia patients
Symptom relief Not yet recruitingThis study tests whether a ketogenic diet (low carb, high fat) is better than a standard diet at preserving muscle function in older adults hospitalized with pneumonia. Researchers will enroll 30 patients aged 55 and older and measure handgrip strength and diet adherence. The goa…
Phase: NA • Sponsor: University of Alabama at Birmingham • Aim: Symptom relief
Last updated Jun 27, 2026 14:02 UTC
-
Root canal relief? study tests weaker bleach for less pain
Symptom relief Not yet recruitingThis study compares two strengths of sodium hypochlorite (a disinfectant used during root canals) to see which causes less pain afterward. 116 adults needing a root canal will be randomly assigned to receive either a 2.5% or 5.25% solution. Pain levels will be measured at 6, 12, …
Phase: NA • Sponsor: College of Physicians and Surgeons Pakistan • Aim: Symptom relief
Last updated Jun 27, 2026 13:01 UTC
-
Dentists test three sealers to find the most comfortable root canal
Symptom relief Not yet recruitingThis study compares three different root canal sealers—AH Plus, ProRoot Bio Sealer, and BC Sealer ion+—to see which one leads to the least pain after treatment. About 135 adults with irreversible pulpitis in a lower molar will be randomly assigned to one of the three sealers. Pat…
Phase: NA • Sponsor: European University of Lefke • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
New study brings lung rehab to africa: can exercise programs help millions?
Symptom relief Not yet recruitingThis study tests whether a supervised exercise and education program (pulmonary rehabilitation) can help people with long-term lung diseases like COPD, asthma, and post-TB lung damage in Nigeria, South Africa, and Cameroon. Researchers will enroll 90 patients to see if the progra…
Phase: NA • Sponsor: University of Edinburgh • Aim: Symptom relief
Last updated Jun 27, 2026 12:37 UTC
-
New Ultrasound-Guided IV could spare newborns painful needle sticks
Symptom relief Not yet recruitingThis study compares two types of IV catheters in 104 newborns with congenital syphilis who need 10 days of antibiotics. One group gets a standard short catheter, the other a longer catheter placed using ultrasound by a specialized nurse. The goal is to see which lasts longer and …
Phase: NA • Sponsor: Hospital de Clinicas de Porto Alegre • Aim: Symptom relief
Last updated Jun 27, 2026 12:31 UTC
-
New root canal sealers aim to reduce Post-Procedure pain
Symptom relief Not yet recruitingThis study will compare two types of root canal sealers, NeoSealer Flo and CeraSeal, in 30 adults needing root canal treatment for painful tooth inflammation. The goal is to see which sealer causes less pain after the procedure and less leakage of material beyond the tooth tip. P…
Phase: NA • Sponsor: Cairo University • Aim: Symptom relief
Last updated Jun 27, 2026 12:30 UTC
-
New study aims to make root canals less painful
Symptom relief Not yet recruitingThis study tests four different ways to clean infected root canals to see which one reduces bacteria and pain the most. Forty adults with tooth infections will be randomly assigned to one of the cleaning methods. The goal is to find a better way to disinfect teeth while making th…
Phase: NA • Sponsor: Suez Canal University • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
Nose ointment may ease Radiation's brutal mouth pain
Symptom relief Not yet recruitingThis study tests whether a common antibiotic ointment applied inside the nose can reduce severe mouth and throat pain caused by radiation therapy in head and neck cancer patients. About 126 participants will receive either the antibiotic or a placebo, and neither they nor their d…
Phase: PHASE2 • Sponsor: David Palma • Aim: Symptom relief
Last updated Jun 27, 2026 12:28 UTC
-
New study aims to make root canals less painful
Symptom relief Not yet recruitingThis study looks at whether using different root canal tools (TruNatomy vs ProTaper Gold) and different sealers (AH Plus vs TotalFill BC) can reduce pain after a root canal. About 144 adults with a tooth infection will take part. They will rate their pain at several times over a …
Phase: NA • Sponsor: European University of Lefke • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Chilled painkiller could cool down Post-Root-Canal pain
Symptom relief Not yet recruitingThis study compares two ways of using an anti-inflammatory drug (ketorolac) during root canal treatment: one at room temperature and one chilled. The goal is to see if the cold version reduces pain better after the procedure. Sixty adults with tooth infections will be enrolled, a…
Phase: PHASE2 • Sponsor: Ain Shams University • Aim: Symptom relief
Last updated Jun 27, 2026 12:08 UTC
-
New vaginal ovule aims to soothe recurrent infections
Symptom relief Not yet recruitingThis study tests a medical device called Rephegyn vaginal ovules to help treat fungal (candidiasis) and bacterial infections. The device is designed to help heal the vaginal lining and reduce symptoms like discharge, pain, and itching. About 34 adults with recurrent infections wi…
Sponsor: Innate srl • Aim: Symptom relief
Last updated Jun 27, 2026 12:07 UTC
-
New study tests light and gel to ease dental pain
Symptom relief Not yet recruitingThis study compares different numbing methods to reduce pain during dental cavity treatment. About 204 adults with tooth decay will receive either a light-based device, a numbing gel, or a placebo before local anesthesia. Researchers will measure pain during and after the procedu…
Phase: NA • Sponsor: Dubai Health • Aim: Symptom relief
Last updated Jun 27, 2026 12:07 UTC
-
New hope for Tick-Bite survivors: mast cell drugs aim to ease lingering symptoms
Symptom relief Not yet recruitingThis study tests whether medications that calm mast cells (ketotifen and cromolyn) can safely reduce persistent symptoms like fatigue, pain, and brain fog in people who had a tick-borne illness. Fifty adults aged 21-65 will receive either one of these drugs or a standard antihist…
Phase: PHASE2 • Sponsor: University of North Carolina, Chapel Hill • Aim: Symptom relief
Last updated Jun 27, 2026 12:07 UTC
-
New natural gel for bacterial vaginosis passes first safety check
Symptom relief Not yet recruitingThis early-stage study tests whether LCFA-01, a natural gel containing oleic acid, is safe and comfortable when placed in the vagina. Thirty healthy women aged 18-40 will use the gel and be monitored for side effects, discomfort, and how much of the product enters the bloodstream…
Phase: PHASE1 • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:04 UTC
-
Tooth pain breakthrough: scaffolds may boost pulp healing!
Symptom relief Not yet recruitingThis study tests whether special scaffolds placed inside a tooth after removing the infected pulp can lower pain and improve healing. About 36 adults with a painful, infected lower molar will be treated and followed for up to a year. The goal is to find a better way to save the t…
Phase: NA • Sponsor: Cairo University • Aim: Symptom relief
Last updated Jun 27, 2026 12:01 UTC
-
Microscope magic? new study tests if High-Tech view saves more teeth
Symptom relief Not yet recruitingThis study compares two ways of doing a pulpotomy (a type of root canal) for adults with a painful, infected tooth. Half the treatments will use a special dental microscope, and half will not. The goal is to see if the microscope helps the tooth heal better over time. Fifty healt…
Phase: EARLY_PHASE1 • Sponsor: Chulalongkorn University • Aim: Symptom relief
Last updated Jun 27, 2026 11:02 UTC
-
Ice vs. spray: which chills root canal pain best?
Symptom relief Not yet recruitingThis study compares two ways of applying cold inside a tooth during a root canal to see which reduces pain better. Ninety adults with a painful, inflamed tooth nerve will be randomly assigned to receive either ice sticks, a cold spray, or no extra cold treatment. Patients will ra…
Phase: NA • Sponsor: Dow University of Health Sciences • Aim: Symptom relief
Last updated Jun 27, 2026 11:01 UTC
-
New tool may ease pain after baby tooth root canals
Symptom relief Not yet recruitingThis study tests whether using a special rotary file (a spinning tool) causes less pain after a baby tooth root canal than the traditional manual file. Fifty children aged 4 to 6 with an infected baby molar will be randomly assigned to one of the two methods. Parents will rate th…
Phase: NA • Sponsor: Cairo University • Aim: Symptom relief
Last updated Jun 27, 2026 09:07 UTC
-
Gut bacteria may help pancreatic surgery recovery
Symptom relief Not yet recruitingThis study tests whether a probiotic called Clostridium butyricum CBM588 can reduce diarrhea and improve quality of life in people who have had their pancreas removed due to cancer or other growths. About 158 patients will take either the probiotic or a placebo for three months a…
Phase: NA • Sponsor: Casa di Cura Dott. Pederzoli • Aim: Symptom relief
Last updated Jun 27, 2026 09:06 UTC
-
Could a cold spray or buzzy gadget make shots less painful?
Symptom relief Not yet recruitingThis study tests whether using a cold spray or a Buzzy device (a vibrating cold pack) can reduce pain and fear during penicillin injections. Ninety adults receiving intramuscular penicillin will be randomly assigned to one of three groups: cold spray, Buzzy device, or standard ca…
Phase: NA • Sponsor: Inonu University • Aim: Symptom relief
Last updated Jun 27, 2026 09:05 UTC
-
New study tests if a faster drill makes kids less scared at the dentist
Symptom relief Not yet recruitingThis study looks at whether using a special rotating tool (rotary file) instead of a hand tool (manual file) during a baby molar root canal (pulpectomy) makes children behave better. It will include 54 children aged 4-6 who need this treatment. The main goal is to see if the rota…
Phase: NA • Sponsor: Cairo University • Aim: Symptom relief
Last updated Jun 27, 2026 09:05 UTC
-
Tooth pain study seeks best numbing technique
Symptom relief Not yet recruitingThis study compares two ways to numb a painful lower back tooth before a root canal. One method uses a standard injection near the jaw nerve, while the other uses a different numbing medicine injected near the tooth. The goal is to see which approach provides better pain relief d…
Phase: NA • Sponsor: Armed Forces Institute of Dentistry, Pakistan • Aim: Symptom relief
Last updated Jun 27, 2026 09:05 UTC
-
Cold therapy may ease root canal pain, new study suggests
Symptom relief Not yet recruitingThis study tests whether applying cold (cryotherapy) to the gums right after a numbing shot can make root canal treatment less painful. About 100 adults with an infected lower premolar tooth will be randomly assigned to receive standard numbing methods with or without the cold tr…
Phase: NA • Sponsor: TC Erciyes University • Aim: Symptom relief
Last updated Jun 27, 2026 09:05 UTC
-
Which sealer hurts less? new trial tests root canal pain relief
Symptom relief Not yet recruitingThis study compares two types of dental sealers used after root canal treatment to see which causes less pain. About 118 adults with painful tooth inflammation will receive either a tricalcium silicate sealer or a resin-based sealer. Pain levels will be measured at 24 hours, 72 h…
Phase: NA • Sponsor: Armed Forces Institute of Dentistry, Pakistan • Aim: Symptom relief
Last updated Jun 27, 2026 09:02 UTC
-
Microscope may ease tooth pain after deep cavity treatment
Symptom relief Not yet recruitingThis study tests whether using a dental operating microscope during a pulpotomy (a partial root canal) reduces pain and improves quality of life afterward. 82 adults with deep cavities and tooth nerve pain will be randomly assigned to get the procedure with or without the microsc…
Phase: EARLY_PHASE1 • Sponsor: Chulalongkorn University • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
Could a common steroid help kids with severe eye infections?
Symptom relief Not yet recruitingThis pilot study tests whether giving dexamethasone (a steroid) to children hospitalized with orbital cellulitis (a serious eye infection) is worth studying further. Thirty children will receive either dexamethasone or a placebo by IV. The main goal is to see if a larger trial is…
Phase: NA • Sponsor: The Hospital for Sick Children • Aim: Symptom relief
Last updated Jun 27, 2026 08:13 UTC
-
Root canal showdown: which sealer hurts less?
Symptom relief Not yet recruitingThis study aims to find out which of two root canal sealers causes less pain after treatment. Sixty adults with tooth nerve inflammation will have root canals and then rate their pain over two days. The goal is to improve patient comfort and recovery.
Phase: PHASE2, PHASE3 • Sponsor: Jaweria Gul Keyani • Aim: Symptom relief
Last updated Jun 27, 2026 08:10 UTC
-
Which pill eases root canal pain best? new study tests two options
Symptom relief Not yet recruitingThis study compares two single-dose pain relievers—piroxicam and prednisolone—given before a root canal to see which one reduces pain better afterward. Sixty adults with an inflamed tooth nerve and infection will take one of the drugs right before treatment. The goal is to find a…
Phase: PHASE4 • Sponsor: RANA AHMAD • Aim: Symptom relief
Last updated Jun 27, 2026 08:04 UTC
-
Could a calming pill ease root canal pain?
Symptom relief Not yet recruitingThis study compares two ways to manage pain after a root canal. One group gets ibuprofen alone, the other gets ibuprofen plus alprazolam, a medicine that reduces anxiety. 110 adults with tooth pain will rate their pain over 24 hours. The goal is to see if adding alprazolam leads …
Phase: NA • Sponsor: Armed Forces Post Graduate Medical Institute (AFPGMI), Rawalpindi • Aim: Symptom relief
Last updated Jun 27, 2026 08:03 UTC
-
Could a malaria drug ease lingering lyme symptoms?
Symptom relief Not yet recruitingThis study tests whether adding hydroxychloroquine (a malaria drug) to standard doxycycline treatment can reduce long-term complaints in adults with Lyme disease. Fifty participants will take either hydroxychloroquine or a placebo twice daily for 28 days, with follow-up visits ov…
Phase: PHASE4 • Sponsor: Radboud University Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 07:58 UTC
-
New study aims to make root canals less painful
Symptom relief Not yet recruitingThis study looks at two ways of cleaning a tooth's root canal to see which one causes less pain afterward. It involves 72 adults with a specific type of tooth nerve pain in their front teeth. Participants will have their root canals cleaned using one of two methods, then rate the…
Phase: NA • Sponsor: RANA AHMAD • Aim: Symptom relief
Last updated Jun 27, 2026 07:52 UTC
-
New HIV prevention drug faces drug interaction test
Knowledge-focused Not yet recruitingThis early-stage study looks at how a common tuberculosis drug, rifampin, affects levels of a new HIV prevention medicine called MK-8527. Fourteen adults with latent TB (no active symptoms) will take MK-8527 with and without rifampin. The goal is to see if the two drugs can be us…
Phase: PHASE1 • Sponsor: Merck Sharp & Dohme LLC • Aim: Knowledge-focused
Last updated Jul 03, 2026 23:00 UTC
-
Pneumonia culprit may be rarer than doctors think
Knowledge-focused Not yet recruitingThis study looks at 200 people with pneumonia to find out how many actually have an infection caused by Chlamydia pneumoniae, a type of bacteria. Researchers will use PCR tests to check for the germ and compare results with standard care. The goal is to see if this infection is o…
Sponsor: Centre Hospitalier de Saint-Denis • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
Massive european TB registry aims to map the disease and sharpen treatment
Knowledge-focused Not yet recruitingThis study collects long-term data from tuberculosis patients across Europe to better understand the disease and its treatment. Researchers track risk factors, diagnostic details, side effects, and outcomes for both drug-sensitive and drug-resistant TB. The goal is to identify wh…
Sponsor: Research Center Borstel • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
Superbug sleuths decode the DNA of drug-resistant e. coli to stop its spread
Knowledge-focused Not yet recruitingThis study examines the genetic makeup of carbapenem-resistant E. coli bacteria collected from patients in southern France. Researchers will sequence the bacteria's full genomes to identify different strains, resistance genes, and virulence factors. The goal is to understand how …
Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
New study uses DNA to track hidden gonorrhea in partners
Knowledge-focused Not yet recruitingThis study will recruit 100 sexual partners of people diagnosed with gonorrhea. Researchers will take an extra throat swab to analyze all the bacteria and their genes using a technique called metagenomics. The goal is to find hidden infections, antibiotic resistance, and see how …
Sponsor: Guy's and St Thomas' NHS Foundation Trust • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
Worldwide ICU infection snapshot aims to save lives
Knowledge-focused Not yet recruitingThis observational study will look at 10,000 adults in intensive care units (ICUs) around the world during a single 24-hour period. Researchers want to find out how common infections and antibiotic-resistant bacteria are, how they are treated, and how patients recover. No new tre…
Sponsor: Universidad de la Sabana • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
Bone marrow secrets may unlock sepsis recovery
Knowledge-focused Not yet recruitingThis study looks at how sepsis affects the bone marrow, where immune cells are made. Researchers will compare bone marrow samples from 45 people: those with sepsis, other critically ill patients, and healthy volunteers. The goal is to understand why sepsis can weaken the immune s…
Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
Heart drug may unlock secrets of blood flow in sepsis
Knowledge-focused Not yet recruitingThis study looks at how esmolol, a drug that slows the heart rate, affects the smallest blood vessels in people with septic shock—a severe infection that can lead to organ failure. Researchers will measure changes in blood flow under the tongue and other key pressures in the circ…
Phase: NA • Sponsor: First Affiliated Hospital of Wannan Medical College • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Can a sedative improve blood flow in septic shock? a pilot study investigates
Knowledge-focused Not yet recruitingThis study looks at how the sedative dexmedetomidine affects the smallest blood vessels in people with septic shock, a life-threatening condition caused by severe infection. Researchers will measure blood flow in the tongue's tiny vessels and other key blood pressure indicators b…
Phase: NA • Sponsor: First Affiliated Hospital of Wannan Medical College • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Could a common vasodilator unclog microvessels in septic shock?
Knowledge-focused Not yet recruitingThis study tests whether the drug papaverine can improve blood flow in the smallest blood vessels of people with septic shock. Septic shock causes widespread inflammation and poor circulation, which can damage organs. The trial will give papaverine intravenously to 20 adults in t…
Phase: NA • Sponsor: First Affiliated Hospital of Wannan Medical College • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Could a Plant-Derived drug improve blood flow in septic shock?
Knowledge-focused Not yet recruitingThis pilot study will test a drug called anisodamine in 20 adults with septic shock who are on a ventilator. The goal is to see if the drug can improve blood flow in small blood vessels and help with a phenomenon called 'vascular waterfall.' This is a very early study to gather i…
Phase: NA • Sponsor: First Affiliated Hospital of Wannan Medical College • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Deworming drug could stop blinding flies
Knowledge-focused Not yet recruitingThis study tests whether a safe dose of ivermectin, a common deworming drug, can make human feces deadly to flies that spread trachoma. Trachoma is a leading cause of blindness, and these flies carry the bacteria from person to person. Twelve healthy adults will take ivermectin, …
Phase: PHASE4 • Sponsor: London School of Hygiene and Tropical Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Vaccine Follow-Up: how long does protection last in babies?
Knowledge-focused Not yet recruitingThis study follows 100 infants who received a pneumococcal vaccine in an earlier trial. Researchers will take a small blood sample to measure antibody levels one and two years after vaccination. The goal is to see how long protection against pneumococcal infections lasts. No new …
Sponsor: CanSino Biologics Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Transplant breakdown? new study checks organ fluid for hidden germs
Knowledge-focused Not yet recruitingThis study looks at whether testing the liquid used to preserve donor livers and kidneys can predict infections in recipients. Researchers will check if bacteria or fungi in that fluid match infections that develop after transplant. The goal is to see if this simple test could he…
Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
New study aims to track dangerous infections in kids with sickle cell disease
Knowledge-focused Not yet recruitingThis study will look at medical records of 350 children with sickle cell disease in France who had serious bacterial infections between 2020 and 2025. The goal is to find out which bacteria are causing these infections today, especially with new vaccines available. The results co…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:08 UTC
-
23,000 seniors join study to unlock secrets of aging and infection
Knowledge-focused Not yet recruitingThis research project aims to understand why older adults get more infections and why those infections can be more serious. By following 23,000 people aged 60 and older, scientists will collect health data and samples like blood and stool to study how the immune system changes wi…
Sponsor: Huashan Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC
-
Can training clinics to be less stigmatizing boost HIV prevention?
Knowledge-focused Not yet recruitingThis study tests whether training healthcare providers to reduce stigma can increase the use of HIV and STI prevention services, like testing and preventive medications. It will involve 8 clinics in the Mississippi Delta and track changes in how often patients receive these servi…
Phase: NA • Sponsor: Albert Einstein College of Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
New drug AZD7760 tested in healthy volunteers for safety
Knowledge-focused Not yet recruitingThis early-stage study tests the safety of a new drug called AZD7760 in 18 healthy Japanese adults. Participants receive a single intravenous dose and are monitored for side effects and how the drug moves through the body. The study does not aim to treat any disease; it only gath…
Phase: PHASE1 • Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
AI to predict cancer risk from gut bacteria and scans
Knowledge-focused Not yet recruitingThis study will collect data from 10,000 people undergoing upper endoscopy to build an AI model that predicts the risk of developing stomach or esophageal cancer. Researchers will combine information from endoscopy images, tissue samples, genetics, and gut bacteria. Participants …
Sponsor: National Taiwan University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:39 UTC
-
Could preterm babies safely get fewer antibiotics?
Knowledge-focused Not yet recruitingThis study looks at whether preterm infants in the NICU can safely stop taking the antibiotic ampicillin after 24 to 36 hours instead of the usual 48 hours. Researchers will measure drug levels in the blood and monitor the babies for any problems. The goal is to see if a shorter …
Phase: PHASE1, PHASE2 • Sponsor: Duke University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:38 UTC
-
Scientists investigate immune system failures in leptospirosis to find better treatments
Knowledge-focused Not yet recruitingThis study looks at how the immune system of people with leptospirosis responds to the infection and to antibiotics. Researchers will collect blood samples from 70 adults in New Caledonia before and after antibiotic treatment to measure immune cell activity. They will also test a…
Sponsor: Institut Pasteur • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:38 UTC
-
AI could revolutionize TB care by predicting who needs shorter treatment
Knowledge-focused Not yet recruitingThis study will use artificial intelligence to analyze data from over 31,000 tuberculosis patients. The goal is to create a system that helps doctors decide which patients can be cured with a short treatment course and which need longer therapy. The AI will be tested to see if it…
Sponsor: Huashan Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:38 UTC
-
Hospital staff TB screening under review: are routine tests necessary?
Knowledge-focused Not yet recruitingThis study looks back at records of over 1,000 new hospital workers in Nice, France, who were tested for latent (hidden) tuberculosis infection as part of their hiring process. The goal is to see how many test positive, what factors increase the risk, and whether the screening le…
Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:38 UTC
-
TB stigma in the UK: a hidden barrier to care?
Knowledge-focused Not yet recruitingThis study looks at how people diagnosed with tuberculosis (TB) in rural and coastal areas of Southwest England experience stigma. Researchers will interview 20 patients to understand how stigma affects their lives and access to care. The goal is to develop better ways to support…
Sponsor: Bournemouth University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:38 UTC
-
Herbal injection may improve circulation in septic shock
Knowledge-focused Not yet recruitingThis small pilot study tests whether a Chinese herbal medicine called Shenfu Injection can improve blood flow in people with septic shock, a life-threatening condition. Twenty adults in the ICU will receive the injection, and doctors will measure changes in circulation and oxygen…
Phase: NA • Sponsor: First Affiliated Hospital of Wannan Medical College • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
Glow of white blood cells may predict sepsis danger in ER
Knowledge-focused Not yet recruitingThis study looks at whether measuring the fluorescence of certain white blood cells (neutrophils) can help doctors quickly identify sepsis patients at risk of severe complications like organ failure or septic shock. Researchers will analyze blood samples from 492 adults in the em…
Sponsor: University Hospital, Strasbourg, France • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:33 UTC
-
New study aims to spot heart trouble early in septic newborns
Knowledge-focused Not yet recruitingThis study will examine heart function in 80 newborns with sepsis using a special ultrasound (tissue Doppler echocardiography) and blood tests for cardiac troponin and other sepsis markers. The goal is to see if these tests can predict heart problems early. The study includes bot…
Sponsor: Assiut University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC
-
FMT vs antibiotics: which works better Long-Term for c. diff?
Knowledge-focused Not yet recruitingThis study looks at adults who had a C. diff infection and were treated with either a fecal transplant (FMT) or antibiotics alone. Researchers want to see if FMT leads to healthier gut bacteria and fewer health problems years later. Participants will give blood, stool, and urine …
Sponsor: Umeå University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Routine pee test before bladder surgery may be unnecessary, major study suggests.
Knowledge-focused Not yet recruitingThis study will include 2,600 adults scheduled for bladder tumor surgery. Half will get a standard urine culture before surgery; the other half will not. The goal is to see if skipping the test leads to more fevers or infections in the month after surgery. If it's safe, it could …
Phase: NA • Sponsor: Poitiers University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:26 UTC
-
Scientists probe gut bacteria after fecal transplants to unlock secrets of chronic disease
Knowledge-focused Not yet recruitingThis study will give fecal transplants to 90 people with recurrent C. difficile infection, ulcerative colitis, or metabolic syndrome. Researchers will use advanced tests on stool and tissue samples to track how donor bacteria settle in the gut and interact with the host. The goal…
Phase: NA • Sponsor: Catholic University of the Sacred Heart • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:24 UTC
-
Scientists hunt for genetic tricks behind superbug's antibiotic shield
Knowledge-focused Not yet recruitingThis study aims to find out how often multi-drug resistant Klebsiella pneumoniae bacteria carry genes that help them form biofilms (sticky layers) and pump out antibiotics. Researchers will collect urine, pus, and sputum samples from 100 hospital patients with these infections. T…
Sponsor: Sohag University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
New antibiotic gepotidacin tested in kids for first time
Knowledge-focused Not yet recruitingThis early-stage study will give a single dose of the experimental antibiotic gepotidacin to 20 hospitalized children aged 2 to 12 who are already receiving standard antibiotics for a bacterial infection or as a preventive measure. Researchers will measure how the drug moves thro…
Phase: PHASE1 • Sponsor: GlaxoSmithKline • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Dental detectives: scientists analyze tooth pulp to improve diagnosis of toothaches
Knowledge-focused Not yet recruitingThis observational study will collect pulp tissue from 1,200 adults during routine dental procedures like root canals or extractions. Researchers will analyze the tissue to understand the immune and inflammatory response at the molecular level. The goal is to see if current diagn…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:08 UTC
-
Free sexual health Check-Ups: will they satisfy young people?
Knowledge-focused Not yet recruitingThis study looks at how satisfied young people and those with low incomes are with free HIV and STI testing and counselling in Lucerne and Zurich. Around 1,800 participants will fill out a questionnaire after their visit. The goal is to see if these free services meet people's ne…
Sponsor: University of Zurich • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC
-
New calculator could slash unnecessary antibiotics in newborns
Knowledge-focused Not yet recruitingThis study will look at how using a risk calculator changes the way doctors manage suspected early-onset sepsis in newborns. Researchers will compare data from before and after the calculator was introduced at one hospital, involving about 6,300 infants. The goal is to see if the…
Sponsor: Hillel Yaffe Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:04 UTC
-
Superbug secrets: can genes make a Last-Resort drug fail?
Knowledge-focused Not yet recruitingThis study looks at whether certain genes in a dangerous superbug (carbapenem-resistant hypervirulent Klebsiella pneumoniae) make it resistant to the powerful antibiotic cefiderocol. Researchers will collect samples from 100 infected patients and test the bacteria in the lab. The…
Sponsor: Sohag University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
New test could spot superbug resistance faster
Knowledge-focused Not yet recruitingThis study looks at a simpler way to detect resistance to colistin, a last-resort antibiotic, in multidrug-resistant bacteria. Researchers will collect 90 samples from hospitalized patients and compare a disk test to the standard method. They will also check for resistance genes …
Sponsor: Assiut University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
New TB risk score could speed up diagnosis and save lives
Knowledge-focused Not yet recruitingThis study aims to create a database of 686 adults with suspected or confirmed tuberculosis at an Italian hospital. Researchers will analyze patient data to build a risk score that helps doctors quickly decide who needs isolation and who can be ruled out. The goal is to improve d…
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:03 UTC
-
Scientists probe genetic switch behind superbug's double defense
Knowledge-focused Not yet recruitingThis study examines 80 samples of Pseudomonas aeruginosa bacteria that are resistant to multiple antibiotics. Researchers will measure the activity of a gene called mexB, which helps the bacteria pump out drugs, and check how much slime (biofilm) the bacteria produce. The goal is…
Sponsor: Assiut University • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:03 UTC
-
New study aims to uncover hidden viruses in feverish infants
Knowledge-focused Not yet recruitingThis study looks at why some babies under 3 months get fevers. It will check for viruses in the nose and stool of 130 febrile infants and compare them to healthy babies. The goal is to better tell apart viral and bacterial infections, which could lead to fewer hospital stays and …
Phase: NA • Sponsor: University Hospital, Montpellier • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:02 UTC
-
Anthrax drug under the microscope: new study tracks Real-World use
Knowledge-focused Not yet recruitingThis observational study will follow up to 10 people in the U.S. who have a confirmed case of systemic anthrax and are treated with the drug raxibacumab. Researchers will track survival, side effects, and drug levels in the blood to better understand how well the treatment works.…
Sponsor: Emergent BioSolutions • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:02 UTC
-
Muscle scans may reveal hidden death risk in ICU patients
Knowledge-focused Not yet recruitingThis study looks at whether muscle measurements from a CT scan taken when a patient is admitted to the ICU for septic shock can predict their risk of dying within 3 months after leaving the ICU. Researchers will analyze muscle size, density, and fat content from the scan and comp…
Phase: NA • Sponsor: Centre Hospitalier Universitaire de Saint Etienne • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:02 UTC
-
TB drug liver risk under the microscope
Knowledge-focused Not yet recruitingThis study will track 220 adults being treated for tuberculosis (TB) or latent TB with the drug isoniazid. Researchers want to see how often the drug causes liver injury and what factors make it more likely. They will also look at how doctors manage this side effect in real-world…
Sponsor: ASST Fatebenefratelli Sacco • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:01 UTC
-
Blood test and ultrasound may spot dangerous stomach ulcers without a scope
Knowledge-focused Not yet recruitingThis study looks at whether combining a blood test for H. pylori bacteria with a painless stomach ultrasound can predict serious complications from peptic ulcers, like bleeding or a hole in the stomach. Researchers will study 230 adults with stomach symptoms to see if these non-i…
Sponsor: Assiut University • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC
-
Leprosy cases in costa rica under the microscope: what can we learn?
Knowledge-focused Not yet recruitingThis study looks back at the medical records of 130 people diagnosed with Hansen's disease (leprosy) in Costa Rica between 2018 and 2025. The goal is to describe the patients, how the disease was diagnosed, what treatments were used, and what complications occurred. No new treatm…
Sponsor: Caja Costarricense de Seguro Social • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC
-
Saliva test could spot tooth nerve inflammation
Knowledge-focused Not yet recruitingThis study looks at inflammation inside the tooth's inner tissue (dental pulp) in people with painful pulpitis compared to healthy individuals. Researchers will measure specific inflammation markers in saliva, gum fluid, and pulp tissue to see if they reflect the level of inflamm…
Sponsor: Université de Nantes • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:11 UTC
-
Massive global study to reveal how septic shock is really treated
Knowledge-focused Not yet recruitingThis study will observe the real-world treatment of 5,000 adults with septic shock in intensive care units across many countries. Researchers want to see how closely doctors follow official guidelines and what factors influence their choices. The goal is to identify gaps in care …
Sponsor: Bicetre Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:11 UTC
-
Can a pamphlet help sepsis patients recover? small study aims to find out
Knowledge-focused Not yet recruitingThis pilot study tests whether giving sepsis survivors a simple educational brochure when they leave the intensive care unit (ICU) is feasible. Researchers will enroll 30 adults with sepsis and randomly assign them to receive either usual care or the brochure plus a chance to ask…
Phase: NA • Sponsor: McMaster University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:10 UTC
-
New study aims to decode Sepsis-Related heart and blood vessel failure
Knowledge-focused Not yet recruitingThis observational study will look at 400 adults with sepsis and unstable blood pressure to understand how their heart and blood vessels are affected. Researchers will use ultrasound and blood tests to classify patients into different groups based on their heart and blood vessel …
Sponsor: Karolinska Institutet • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:09 UTC
-
Heart ultrasound may guide better septic shock treatment
Knowledge-focused Not yet recruitingThis study will use echocardiograms (heart ultrasounds) to see how the heart responds to two common treatments for septic shock: intravenous fluids and vasopressors (medicines that raise blood pressure). Researchers will measure changes in heart function before and 15 minutes aft…
Sponsor: Mahidol University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:08 UTC
-
Antibiotic penetration study aims to improve infection treatment
Knowledge-focused Not yet recruitingThis study looks at how the antibiotic delafloxacin spreads through the body in 20 adults with serious skin, soft tissue, bone, or joint infections. Researchers will measure drug levels in blood and in tissues collected during surgery. The goal is to understand if the drug reache…
Sponsor: IRCCS San Raffaele • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:07 UTC
-
Massive saudi study aims to improve emergency surgery survival
Knowledge-focused Not yet recruitingThis study will collect data from 10,000 patients across Saudi Arabia who undergo emergency abdominal surgery (laparotomy). Researchers will track complications and deaths within 30 and 90 days after surgery. The goal is to understand current care quality, test international risk…
Sponsor: King Faisal Specialist Hospital & Research Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:07 UTC
-
Paris network tracks rare Flesh-Eating infections to improve survival
Knowledge-focused Not yet recruitingThis study follows 1,000 patients with rare, life-threatening skin and soft tissue infections who are treated through a special care network in the greater Paris area. Researchers will track survival rates, long-term complications, and quality of life to understand what factors a…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:06 UTC
-
New study aims to catch TB in pregnant women earlier
Knowledge-focused Not yet recruitingThis study will test better ways to screen for tuberculosis (TB) in pregnant and postpartum women in Guinea-Bissau. Researchers will use a symptom checklist, stool tests, and AI-powered chest X-rays to find more TB cases. The goal is to improve health for mothers and babies and g…
Phase: NA • Sponsor: Aarhus University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:06 UTC
-
Nurses train to detect silent organ threat in sepsis
Knowledge-focused Not yet recruitingThis study looks at whether intensive care nurses can learn to use a special ultrasound method called VExUS to find early signs of blood buildup in the veins of sepsis patients. Sepsis can cause organ damage, and this buildup may make it worse. The study will train nurses, check …
Sponsor: Region Örebro County • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:06 UTC
-
Hospital root canal study aims to improve dental outcomes
Knowledge-focused Not yet recruitingThis study will follow 75 adults who need root canal treatment or retreatment at a hospital dental clinic in Rome. Researchers will check how well the teeth heal using X-rays and symptom reports over up to 5 years. The goal is to understand success rates and how factors like over…
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC
-
Blood ratio may replace fancy machines in ICU nutrition monitoring
Knowledge-focused Not yet recruitingThis study looks at whether the urea-to-creatinine ratio in blood can track metabolic changes in patients with septic shock. Currently, doctors use a special machine (indirect calorimetry) to measure energy needs, but it's not always available. Researchers will compare the simple…
Sponsor: Hospital Sao Domingos • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC
-
Can virtual care cut hospital errors? duke launches massive study
Knowledge-focused Not yet recruitingThis study will see if using virtual care technologies in hospital units can reduce problems like patient falls, infections, and readmissions, while also improving patient satisfaction. About 10,000 adults admitted to six hospital units will take part, with three units using the …
Sponsor: Duke University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC
-
New study aims to improve care for joint infection patients by listening to their stories
Knowledge-focused Not yet recruitingThis study will interview 63 people, including patients with prosthetic joint infections, their family members, and healthcare professionals, to understand their experiences. The goal is to use this information to create a therapeutic education program that helps patients manage …
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:04 UTC
-
Breastfeeding women finally included in TB drug research
Knowledge-focused Not yet recruitingThis study looks at how five common tuberculosis drugs move into breast milk after a single dose. Sixty healthy breastfeeding women in Indonesia will each receive one drug, and researchers will measure drug levels in their blood and milk. The goal is to gather safety data so that…
Phase: PHASE1 • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:03 UTC
-
Immune cell clues may unlock better HS treatment
Knowledge-focused Not yet recruitingThis study looks at how certain immune cells, called MAIT cells, behave in people with hidradenitis suppurativa (HS), a painful skin condition. Researchers will take skin and blood samples from 45 adults with HS and compare them to samples from people with other skin diseases. Th…
Phase: NA • Sponsor: Hospices Civils de Lyon • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:02 UTC
-
Gut health linked to Kids' respiratory infections in new study
Knowledge-focused Not yet recruitingThis study will examine gut bacteria, immune markers, and nutrient levels in 120 children with different respiratory health conditions, including pneumonia and recurrent infections, compared to healthy kids. By analyzing stool samples and health data, researchers hope to understa…
Sponsor: Min-Tze LIONG • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:01 UTC
-
Blood test could unlock secrets of lung disease immunity
Knowledge-focused Not yet recruitingThis study looks at how the immune system works in people with lung diseases like asthma, COPD, pneumonia, and tuberculosis. Researchers will take a single blood sample from 100 adults to study immune cell changes during inflammation and infection. Participants won't receive dire…
Sponsor: Research Center Borstel • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:01 UTC
-
30,000 blood samples could revolutionize rapid disease testing
Knowledge-focused Not yet recruitingThis study will collect blood samples from 30,000 adults in the UK with various health conditions, including blood clots, infections, heart disease, diabetes, and more. The samples will be used to develop and fine-tune new diagnostic tests for the cobas® lumira device, which allo…
Sponsor: LumiraDx UK Limited • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC
-
Scientists investigate mysterious lung infection in south china
Knowledge-focused Not yet recruitingThis study looks at a lung infection called NTM lung disease in South China. Researchers will review medical records of about 1,500 patients and collect samples from around 100 current patients to learn how the immune system reacts. The goal is to help doctors diagnose and manage…
Sponsor: Eighth Affiliated Hospital, Sun Yat-sen University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC
-
New hope against superbug: antibiotic combo targets resistant klebsiella
Knowledge-focused Not yet recruitingThis study will test the antibiotic combination ceftazidime-avibactam on 100 patients with healthcare-associated infections caused by carbapenem-resistant Klebsiella pneumoniae. Researchers will collect samples from blood, urine, and other sites to identify the bacteria and check…
Sponsor: Sohag University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC
-
Can your immune system predict lung infection worsening?
Knowledge-focused Not yet recruitingThis study looks at how the body's immune response and nutrition are linked to the progression of nontuberculous mycobacterial pulmonary disease (NTM-PD), a chronic lung infection. Researchers will analyze immune cells from the lungs and blood of 50 adults with confirmed or suspe…
Sponsor: Seoul National University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:13 UTC
-
Blood markers may predict joint infection treatment success
Knowledge-focused Not yet recruitingThis study will check if certain blood markers (like NLR and PLR) can predict how well people recover after surgery for a joint infection. Researchers will follow 200 adults who need a two-stage joint replacement revision. The goal is to find cheap, easy tests that help doctors p…
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:13 UTC
-
Quick fingerprick test could curb infection spread in rural west virginia
Knowledge-focused Not yet recruitingThis study looks at whether a rapid fingerstick test that gives results in 10-20 minutes can help more people get screened for HIV, hepatitis C, and syphilis during mobile clinic visits. About 200 patients of the WVU Street Medicine team can choose the rapid test, a traditional b…
Sponsor: West Virginia University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:13 UTC
-
Can the Body's own 'Off Switch' for inflammation predict who survives severe infection?
Knowledge-focused Not yet recruitingThis study will follow 300 adults with severe infections in the ICU to see how levels of specialized pro-resolving mediators (SPMs)—natural molecules that help stop inflammation—change over time. Researchers will use blood samples already collected during routine care, so no extr…
Sponsor: Second Affiliated Hospital of Wenzhou Medical University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:12 UTC
-
Hidden Tick-Borne arthritis under investigation in denmark
Knowledge-focused Not yet recruitingThis study aims to find out how common Borrelia arthritis is in Denmark and how it affects patients. Researchers will test blood and joint fluid from 350 adults with joint swelling to look for Borrelia bacteria. Participants will also answer questions about symptoms and tick expo…
Sponsor: Fredrikke Christie Knudtzen • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:12 UTC
-
Scientists decode hidden links in deadly tropical infection
Knowledge-focused Not yet recruitingThis study aims to understand how the environment, the bacteria that cause melioidosis, and the human body interact to cause disease. Researchers will follow about 1,000 infected patients and 1,000 healthy matched controls in Thailand, Laos, and Cambodia for one year. They will a…
Sponsor: University of Oxford • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:12 UTC
-
Gut bug to heart threat: scientists investigate hidden path to deadly infection
Knowledge-focused Not yet recruitingThis study looks at why a common gut bacterium, Enterococcus faecalis, sometimes travels to the heart and causes a serious infection called infective endocarditis. Researchers will analyze the gut bacteria of 90 adults with this bloodstream infection to see if an imbalance in the…
Phase: NA • Sponsor: University Hospital, Clermont-Ferrand • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:09 UTC
-
Could a simple chest monitor replace ultrasound for septic shock patients?
Knowledge-focused Not yet recruitingThis study will enroll 100 adults with septic shock to compare two non-invasive methods for measuring how well the heart is pumping blood: standard ultrasound (echocardiogram) and a newer device called electrical cardiometry, which uses sensors on the chest. The goal is to see if…
Sponsor: Assiut University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:08 UTC
-
Could a stomach bug be messing with your mood?
Knowledge-focused Not yet recruitingThis study will look at 130 people with H. pylori-related gastritis to see if the infection is linked to anxiety, depression, or other psychological symptoms. Researchers will also check whether treating the infection improves mental health. The goal is to better understand the c…
Sponsor: Assiut University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:08 UTC
-
Gas relief drug may skew stomach bug tests, new study warns
Knowledge-focused Not yet recruitingThis pilot study will check if simethicone, a medicine used to reduce gas during endoscopy, makes it harder to detect H. pylori bacteria. About 100 adults with a positive H. pylori test will take simethicone or a placebo before their procedure. The goal is to see if the drug lowe…
Phase: NA • Sponsor: Asian Institute of Gastroenterology, India • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:08 UTC
-
Rare infection study aims to save lives by uncovering hidden clues
Knowledge-focused Not yet recruitingThis study looks back at 400 adults in France who had a rare but serious blood vessel infection caused by the bacteria Coxiella burnetii. The goal is to learn why some patients die within two years and how to diagnose the infection faster. Researchers will review medical records …
Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:06 UTC
-
Tiny molecules may reveal clues about stomach infections in kids
Knowledge-focused Not yet recruitingThis study will measure two molecules, called miRNA-155 and miRNA-204, in stomach tissue from 100 children with ongoing belly pain. The goal is to see if these molecules are linked to gastritis (stomach inflammation) and infection with H. pylori bacteria. Researchers will use spe…
Phase: NA • Sponsor: Benha University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:06 UTC
-
Rapid STI tests for Moms-to-Be: a game changer?
Knowledge-focused Not yet recruitingThis study tests whether point-of-care STI tests, which give results in about 10 minutes, can speed up treatment for pregnant women compared to standard lab tests. About 756 pregnant women at Grady Memorial Hospital will either get the rapid tests or standard testing. The goal is…
Phase: NA • Sponsor: Emory University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:05 UTC
-
Gut bacteria clues: h. pylori and IBD under the microscope
Knowledge-focused Not yet recruitingThis study will check how common Helicobacter pylori infection is in 100 adults with inflammatory bowel disease (Crohn's or colitis) at the Guadeloupe hospital. Researchers will take extra stomach biopsies during routine endoscopy to study the stomach's bacteria. The goal is to s…
Sponsor: Centre Hospitalier Universitaire de la Guadeloupe • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:05 UTC
-
Are ICU patients getting the right antibiotic dose? new study aims to find out
Knowledge-focused Not yet recruitingThis study looks at whether standard antibiotic doses are effective for ICU patients on ECMO (heart-lung support) or kidney dialysis. Researchers will measure drug levels in 40 adults with serious infections. The goal is to see if dosing adjustments are needed to avoid under- or …
Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:04 UTC
-
Are GPs missing the mark on h. pylori? new study investigates
Knowledge-focused Not yet recruitingThis study will survey 300 general practitioners in Upper Egypt to evaluate their knowledge, attitudes, and practices regarding Helicobacter pylori infection. Researchers aim to identify common barriers that prevent proper diagnosis and treatment. The goal is to highlight gaps th…
Sponsor: Assiut University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:04 UTC
-
Toothache science: proteins may reveal why some pulpitis hurts more
Knowledge-focused Not yet recruitingThis study looks at certain proteins (aquaporins and IL-8) in the fluid and tissue of healthy teeth and teeth with a painful, inflamed nerve (irreversible pulpitis). Researchers will collect samples from 70 adults during routine root canal treatment to compare protein levels. The…
Sponsor: Kırıkkale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:00 UTC
-
Hormone levels in septic shock patients to be measured in new study
Knowledge-focused Not yet recruitingThis study will measure thyroid and adrenal hormone levels in 200 ICU patients with septic shock. The goal is to understand how these glands are affected during severe infection. No treatment is given; the study only observes and records hormone changes.
Sponsor: Assiut University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:00 UTC
-
Personalized antibiotic dosing could save lives in the ICU
Knowledge-focused Not yet recruitingThis study aims to find the best way to dose the antibiotic ceftazidime for patients in intensive care with serious infections. Many ICU patients don't get enough of the drug because their bodies process it differently. The researchers will test a personalized dosing plan to keep…
Phase: NA • Sponsor: Centre Hospitalier Universitaire de Saint Etienne • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:59 UTC
-
New study aims to bring mental health support to people with neglected skin diseases in ghana
Knowledge-focused Not yet recruitingThis study will test a new way to care for people in Ghana who have both a neglected tropical skin disease (like leprosy or Buruli ulcer) and mental health challenges like depression or anxiety. Researchers will work with 200 affected adults and local health workers to create a G…
Phase: NA • Sponsor: Liverpool School of Tropical Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:59 UTC
-
Charcoal may skew lab results, study warns
Knowledge-focused Not yet recruitingThis study looks at whether taking activated charcoal can change certain blood test results, like osmolality and ethylene glycol levels. Eight healthy volunteers will take a dose of charcoal and have blood drawn over six hours. The goal is to see if charcoal causes false positive…
Sponsor: State University of New York - Upstate Medical University • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:55 UTC
-
Simple cord blood test may detect fetal infection early
Knowledge-focused Not yet recruitingThis study looks at whether measuring IL-6 and lactate in cord blood can detect early signs of infection or inflammation in full-term newborns. Researchers will compare 160 women whose fetal heart rate patterns suggest possible inflammation with those whose patterns are normal. I…
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:53 UTC
-
Hidden TB threat in dialysis patients: new study to reveal true numbers
Knowledge-focused Not yet recruitingThis study will test 200 adults on regular hemodialysis at Sohag University Hospital for latent tuberculosis infection (LTBI) using a simple skin test. The goal is to find out how many dialysis patients carry the bacteria without symptoms, so doctors can better prevent active TB …
Sponsor: Sohag University • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:53 UTC
-
New rapid test could help ICU doctors pick the right antibiotic hours faster
Knowledge-focused Not yet recruitingThis study tests a new rapid diagnostic system that can tell doctors which antibiotic will work against a blood infection in 4-6 hours, instead of the usual 18-24 hours. Researchers want to see if this faster information helps ICU doctors change to a better antibiotic sooner. The…
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:52 UTC
-
Superbug risk in preterm pregnancy: new study seeks answers
Knowledge-focused Not yet recruitingThis study looks at how often pregnant women who have their water break early carry antibiotic-resistant bacteria. Researchers will collect samples from 250 women across French hospitals to track these bacteria and identify risk factors. The goal is to help doctors choose better …
Sponsor: Centre Hospitalier de Saint-Denis • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:52 UTC
-
Quick blood test could spot ICU patients at highest risk of death
Knowledge-focused Not yet recruitingThis observational study tests a new bedside device that measures nucleosome levels in the blood of critically ill ICU patients. Researchers want to see if these levels can predict which patients are likely to die within 30 days. The study will enroll 130 adults with conditions l…
Sponsor: Erasme University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:51 UTC
-
Arterial line blood draws could revolutionize ICU infection detection
Knowledge-focused Not yet recruitingThis observational study will compare blood cultures taken from arterial lines versus standard vein punctures in 1,500 ICU patients. The goal is to see if the arterial method reduces contamination and improves detection of bloodstream infections. Researchers will also check if mo…
Sponsor: Meir Medical Center • Aim: Knowledge-focused
Last updated Jun 26, 2026 18:54 UTC
-
Learning to avoid infections: study tests education for catheter patients
Knowledge-focused Not yet recruitingThis study looks at whether teaching patients about catheter care can improve their attitudes toward preventing infections and lower their anxiety after urologic surgery. About 70 male patients who go home with a urinary catheter will receive a training booklet based on daily liv…
Phase: NA • Sponsor: Istanbul University - Cerrahpasa • Aim: Knowledge-focused
Last updated Jun 26, 2026 17:17 UTC
-
New study aims to uncover hidden TB drug resistance
Knowledge-focused Not yet recruitingThis study will test 250 people with tuberculosis (TB) to see how common drug resistance is. Using special rapid tests called GeneXpert, researchers will look for resistance to key TB drugs like Rifampicin. They also want to find out if things like diabetes or drug addiction make…
Sponsor: Sohag University • Aim: Knowledge-focused
Last updated Jun 26, 2026 16:51 UTC
-
ICU antibiotic dosing under the microscope: new study targets dialysis clearance
Knowledge-focused Not yet recruitingThis study looks at how the antibiotics piperacillin and tazobactam are cleared from the body by continuous kidney replacement therapy in intensive care patients with severe infections. Researchers will measure drug levels in 24 adults to better understand dosing needs. The goal …
Sponsor: University Hospital, Rouen • Aim: Knowledge-focused
Last updated Jun 26, 2026 16:48 UTC
-
Tooth decay clues: scientists measure inflammation markers to improve Kids' dental care
Knowledge-focused Not yet recruitingThis study looks at 58 children with deep cavities in their baby molars. Dentists will perform a pulpotomy (removing the infected nerve and sealing the tooth) and measure levels of cytokines—substances that signal inflammation—in the pulp. The goal is to see if these levels can p…
Phase: NA • Sponsor: Cairo University • Aim: Knowledge-focused
Last updated Jun 26, 2026 16:36 UTC
-
New blood test could revolutionize TB treatment monitoring
Knowledge-focused Not yet recruitingThis study in Kenya will test whether a new blood test, called PATHFAST TB LAM ag, can better track how well tuberculosis (TB) treatment is working. Researchers will follow 300 adults with TB, collecting samples regularly during their 6-month treatment. The goal is to see if chan…
Sponsor: Nagasaki University • Aim: Knowledge-focused
Last updated Jun 26, 2026 16:14 UTC
-
Brain scan study aims to decode nocardiosis recovery
Knowledge-focused Not yet recruitingThis study will review medical records of 60 people treated for brain nocardiosis, a rare infection. Researchers want to see how brain lesions change on MRI or CT scans during treatment and whether those changes relate to patient outcomes. The goal is to better understand what re…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 26, 2026 16:13 UTC
-
New model aims to crack the code on antibiotic-resistant sepsis in the ER
Knowledge-focused Not yet recruitingSepsis is a life-threatening reaction to infection, and choosing the right antibiotic quickly is critical. This study will analyze data from 10,000 adults treated for sepsis in an emergency department to build a predictive model that estimates the likelihood of multidrug-resistan…
Sponsor: Hospital Italiano de Buenos Aires • Aim: Knowledge-focused
Last updated Jun 26, 2026 15:31 UTC
-
New study aims to decode dangerous fungal infections in cancer patients
Knowledge-focused Not yet recruitingThis study will collect medical information and samples from 300 cancer patients who have or are at risk for a serious fungal infection called mucormycosis. Researchers hope to learn more about how the infection develops and how to better diagnose and manage it. Participants will…
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Jun 26, 2026 15:07 UTC
-
Could a stomach infection worsen lupus? new study investigates
Knowledge-focused Not yet recruitingThis observational study will check if having an H. pylori stomach infection is linked to more active lupus in 115 adults. Researchers will use a stool test to detect the bacteria and a standard lupus score to measure disease activity. No treatments are given; the goal is simply …
Sponsor: Assiut University • Aim: Knowledge-focused
Last updated Jun 26, 2026 14:10 UTC